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ABSTRACT
Outbred Swiss Webster mice were used as an 
experimental model for bovine pneumonic pasteurellosis. 
Using light microscopy and transmission electron 
microscopy to evaluate lesions, it was determined that 
intrabronchial inoculation of Pasteurella haemolytica 
serotype 1 induces dose dependent pulmonary lesions in 
the mouse. Five X 10^ colony forming units was the 
optimum dose which induced lesions and allowed survival 
for at least 24 hours.
Using the optimum dose of inoculum, lesions were 
evaluated at different time points to determine when 
neutrophil influx into the lung first occurred. Four 
hours post inoculation was the minimum time required for 
neutrophil influx to be a significant component of the 
pulmonary lesions.
Neutrophil involvement in pulmonary lesions induced 
by Pasteurella haemolytica infection was evaluated using 
the mouse model. Mice were inoculated with one of three 
inocula: 1) Pasteurella haemolytica. 2) carbon particles, 
(phagocytosis control), or 3) saline (negative control). 
Mice from each inoculation group were subdivided into 
groups receiving one of the following pretreatments:
1) none, 2) indomethacin, an inhibitor of cyclooxygenase,
3) nordihydroguaiaretic acid (NDGA), an inhibitor of
xi
lipoxygenase, or 4) hydroxyurea (neutrophil depleted 
controls). Lesions were evaluated at 4 and 24 hours by 
light microscopy, transmission electron microscopy, serum 
and pulmonary lavage fluid enzyme level analysis, blood 
and lavage cell counts, and ultrastructural examination 
of pulmonary lavage cells.
Morphologically, NDGA pretreated Pasteurella 
inoculated mice had less severe lesions at 4 and 24 hours 
than non-pretreated or indomethacin pretreated 
Pasteurella inoculated mice. Hydroxyurea pretreated mice 
had the least severe lesions of all groups except the 
saline inoculated controls. No detectable differences 
were seen in carbon phagocytosis among the 4 pretreatment 
groups at 4 or 24 hours. Beta-glucuronidase/lavage cell, 
elastase/lavage cell, and myeloperoxidase/lavage cell 
levels were all lower in NDGA pretreated Pasteure1 la 
inoculated mice than in the other pretreatment groups at 
4 hours, however, these changes were not statistically 
significant. The trend continued at 24 hours with 
elastase/lavage cell, but not the other two enzymes.
Modulation of release of the enzymes may have 
contributed to the decreased pulmonary lesions in NDGA 
pretreated Pasteurella inoculated mice seen at the 
morphologic level.
xii
CHAPTER 1 
Literature Review 
Bovine respiratory disease continues to be one of the 
major causes of economic loss to the cattle industry 
despite years of research by numerous investigators. 
Previous and present research deals with etiologic 
factors, epidemiology, pathogenesis of pulmonary lesions 
and preventive measures including alteration of management 
techniques and vaccination. Even though these studies have 
provided useful information about the disease, the 
estimated cost of bovine respiratory disease to the cattle 
industry is still in the range of $250 million to $750 
million annually (1,2).
The variety of terms used to describe fibrinous 
pneumonia of cattle, often seen following transportation 
or other stressors, is indicative of the variety of 
etiologic factors incriminated in the disease. The term 
"shipping fever" is widely used to describe the problem in 
North America and the disease frequently occurs following 
transport of calves to feedlots. The condition was 
originally considered to be the "pulmonary form of 
haemorrhagic septicemia" by Kinsley (3) in 1915. The term 
"transit fever" has been widely used in Britain to
1
2describe the same disease (4,5).
Bovine pneumonic pasteurellosis and bovine 
respiratory disease complex are terms used more recently 
and with increased frequency to describe "shipping fever". 
However, Schiefer, e_t aJL (6) argue that the term 
pasteurellosis may be misleading since Pasteurella 
haemolytica (Ph) and Pasteurella multocida may produce 
different morphologic lesions. The term bovine respiratory 
disease complex (BRDC) has been used to describe three 
clinical entities: enzootic pneumonia of calves, shipping 
fever complex, and atypical interstitial pneumonia (7). 
However, many researchers use this term to specifically 
mean shipping fever and some authors use the two terms 
synonymously (8,9). Various other terms used to describe 
the condition include: stockyards fever, stockyards 
pneumonia, exposure disease and fibrinous pneumonia 
(10,11). At present the definition given by Yates (12) 
probably best describes the condition: "Shipping fever is 
an entity within the bovine respiratory disease complex.
It is a pneumonic condition of cattle which is of 
undetermined though multifactorial etiology, and is 
usually associated with Pasteurella haemolytica or, less 
commonly Pasteurella multocida, in which instances the 
term pneumonic pasteurellosis can be used synonymously. 
Shipping fever is characterized pathologically by lobar, 
anteroventrally distributed, exudative pneumonia in which
3fibrin is usually a prominent part of the exudate and 
fibrinous pleuritis is common."
A variety of etiologic factors including stress, 
viral organisms, bacterial organisms and any combination 
of these factors has been implicated as the cause of the 
bovine respiratory disease complex. Environmental and 
management factors which might induce stress include 
climatic conditions, overcrowding, transporting over long 
distances, weaning, dehorning, dipping, castration and 
vaccination (13,14,15). These stress factors may be enough 
to severely interfere with body defense mechanisms. Lillie 
(13) in summarizing the work of several researchers states 
that: "dusts, cold, sudden and extreme changes of 
temperature and relative humidity, dehydration, hypoxia, 
cortisone, endotoxin, cold coupled with wetness, acute 
metabolic upsets (e.g. acidosis), prior exposure to 
viruses and the species of bacteria to which the lung is 
exposed all have been shown to affect the clearance of 
inhaled bacteria by the lung in a measurable and usually 
inhibitory way." Besides these stressful factors the 
mixing of cattle from various sources in sale barns, 
during shipping, and at shipping destinations provides 
excellent opportunity for the spread of infectious agents.
Another factor important in the bovine respiratory 
disease complex is the effect of respiratory viruses and 
in particular their interactions with bacteria in causing
4disease. Rosenquist (16) lists ten viruses belonging to 
six virus families which cause bovine respiratory disease 
in the United States. Infectious bovine rhinotracheitis 
virus (IBR, BHV-1), bovine viral diarrhea virus (BVDV), 
parainfluenza-3 virus (PI-3), bovine respiratory syncytial 
virus (BRSV) and rhinoviruses are the most likely to be of 
importance. Of these viruses, PI-3, BHV-1, and BVDV have 
received the most attention experimentally for their 
potential involvement in the bovine respiratory disease 
complex (13,17-22).
The most widely accepted theory for the involvement 
of viruses in the BRDC is that the viruses produce 
lesions, immune suppression or functional alterations 
which allow bacterial infection to occur. Ph is the most 
frequently isolated microorganism from field cases of 
BRDC (12,23-26). Other bacteria isolated with less 
frequency include Pasteurella multocida. Corynebacterium 
pyogenes, and Haemophilus somnus (24,27,28). A number of 
mycoplasma species have been isolated from the 
respiratory tracts of cattle (27,29). Mycoplasma 
bovirhinis. Mycoplasma bovis, Mycoplasma dispar, and 
Ureaplasma species are the most frequently isolated 
(29,30). Although several species have experimentally 
caused pneumonia in gnotobiotic calves, the role of 
mycoplasmas in BRDC has not been determined since they 
are isolated both from pneumonic lungs and from lungs of
5healthy calves (30,31).
Experimental models of the BRDC in cattle have 
concentrated on inoculations with Pasteurella species 
or inoculations with viruses followed by Pasteurella 
species. The role of viral-bacterial interactions in 
producing pulmonary disease has been discussed by Jakab 
(32,33). Among the factors Jakab lists as mechanisms 
involved in virus induced suppression of pulmonary 
antibacterial defenses are: enhanced susceptibility to 
bacterial attachment, enhanced susceptibility to 
bacterial colonization, diminished mucociliary clearance, 
decreased surfactant levels, and alveolar macrophage 
dysfunctions (32). With the multitude of viruses and 
bacteria isolated and implicated as etiologic agents in 
the BRDC it seems likely that viral-bacterial interaction 
plays a role in the pathogenesis of the disease. Two 
studies in the 1970’s provided evidence for the 
interaction of viruses and Pasteurella haemo1ytica 
serotype 1 (Phi) in the bovine lung. In one study PI-3 
virus exposure was shown to depress bacterial clearance 7 
and 11 days later (34). In the second study Jericho and 
Langford (35) reported that aerosols of BHV-1 followed by 
aerosol of Phi produced pneumonic lesions similar to 
those seen in field cases of BRDC. J[n vitro studies by 
Forman and Babiuk (36) showed that BHV-1 infected bovine 
alveolar macrophages had marked alterations in
6immunological activity as early as two hours after 
infection. Yates, Babiuk and Jericho (37) report that 
synergism between BHV-1 and Pasteurella haemolytica 
produced lesions when aerosols were given 4, 10, 20, and 
30 days apart but were maximal at 4 days. Jericho, Darcel 
and Langford (22) found that aerosols of PI-3 followed by 
aerosols of Pasteurella haemolytica produced extensive 
purulent pneumonia in calves.
Bovine viral diarrhea virus has also been associated 
with BRDC. Reggiardo (38) stated that BVDV is the virus 
most often isolated from pneumonic lungs of feedlot calves 
in the Texas panhandle, usually in association with Phi. 
Experimentally, BVDV inoculation followed by Phi 
inoculation by aerosol in 6 days does not produce disease, 
whereas, Phi inoculation 10 days post BVDV inoculation 
produces disease (39). In bacterial clearance studies 
Lopez, ejt a_l (40) found no effect on clearance of Phi in 
calves following infection with BVDV. In contrast, 
Potgieter, ejt a_l (41) detected impaired clearance of Phi 
following infection with two different strains of BVDV, a 
cytopathogenic virus and a non-cytopathogenic virus. 
Respiratory tract disease was also produced in calves 
infected with both strains of BVDV when sequentially 
inoculated endobronchially with Phi.
From these studies it must be concluded that viral- 
bacterial interactions play a role in the pathogenesis of
7BRDC. Although the search for specific mechanisms each of 
these viruses utilizes continues, a statement by Jakab 
that, "Clearly, multiple mechanisms are involved in the 
virus-induced suppression of pulmonary antibacterial 
defenses, and to invoke a single mechanism as the cause 
of virus associated bacterial superinfections would be an 
oversimplification" should be kept in mind (32).
Although many factors are involved in the 
phthogenesis of naturally occurring BRDC the fact remains 
that Phi is the most frequently isolated organism from 
these cases (12,23-26). The disease complex is the result 
of many interactions which may have a cumulative effect on 
the host, whereas, experimental attempts to produce 
disease using isolated stressors or pathogens may fail 
(24). With this in mind Babiuk, ejt aJL (24) describes four 
basic types of models which are used to produce bacterial 
pneumonia in cattle with Phi inoculations: 1) direct 
deposition of Phi into the lung, 2) impairment of host 
defenses, 3) alteration of bacterial characteristics, and
4) injury to lungs via inflammatory processes.
Pneumonias produced by viral-bacterial interactions 
are examples of models which impair host defenses. The 
inability of phagocytes to kill phagocytosed bacteria 
illustrates one way in which viruses may impair host 
defenses (42,43). Inhibition of phagosome-1ysosome fusion 
is one mechanism which results in decreased bacterial
8killing (32). Another example of impairment of host 
defenses as a model is by inducing lung edema with 
endotoxin resulting in decreased clearance of Phi (44).
Alteration of bacterial characteristics has been 
achieved by creating microcolonies of bacteria embedded in 
agar beads (24). Phagocytosis of the beads is prevented by 
the size of the beads, however, bacterial growth continues 
and when high enough numbers are reached normal clearance 
mechanisms of the lung are ineffective. This method has 
not been reported with Phi inoculation (24), but has been 
used in rats with Pseudomonas aeruginosa (45). Babiuk, ej: 
al (24) cite studies showing that iron is known to play a 
significant role in bacterial growth and pathogenesis 
(46,47) and state that increased levels of iron may be 
sufficient to increase pathogenicity and virulence of 
Pasteurella in cattle under field conditions.
Injury to lungs via inflammatory processes may occur 
no matter what the initial insult whether it is viral, 
bacterial, a combination, or other cause. Accumulation of 
leukocytes with subsequent release of biological mediators 
at sites of injury may be detrimental to host tissue (48). 
If allowed to continue in an uncontrolled fashion, 
increased disease and even death of the individual may be 
the final outcome (24).
Models utilizing direct deposition of Pasteurella 
into the lung have been used in cattle, thereby, bypassing
9the defense mechanisms of the upper respiratory tract (49- 
53). Friend, _et a_l (50) caused disease by intratracheal 
inoculation with large doses of Phi, Wilkie and Markham 
(52) used intrabronchial deposition of inoculum, and 
Panciera and Corstvet (51) and Newman, ejt a_l (53) produced 
lesions with transthoracic intrapulmonic injection of 
inoculum. Other techniques involve the use of fiberoptic 
bronchoscopy to place inoculum directly in the lung (54) 
or the use of surgically placed indwelling catheters 
directly into the caudal lung lobe (55-57). This latter 
procedure allows for the use of multiple lung lavages of 
the lesion site on the same animal as a monitoring 
technique.
Even though the use of these different types of 
models in the bovine has produced much useful information 
about BRDC, research using cattle is often slow and 
prohibitively expensive. Therefore, there is considerable 
interest in the use of laboratory animals as models for 
BRDC.
Mice have been used extensively to study pulmonary 
function and respiratory disease. Pulmonary response has 
been evaluated with respect to bacterial clearance 
following inoculation with gram negative and gram positive 
bacteria (58-62) and clearance following instillation of 
particulate material (63-68). The majority of the 
particulate studies deal primarily with the adaptive
10
responses of the pulmonary macrophage system in 
phagocytizing the particles, however, Adamson and Bowden 
(66) also report on chemotactic components of the system 
for neutrophils* Bacterial clearance studies are used to 
measure the reaction of the respiratory defense mechanisms 
under various conditions. As examples of how this type of 
model has been used Toews, £t a_l (59) and Rehra, et a_l (60) 
reported that neutrophils play a major role in the 
clearance of two gram negative organisms, Klebsiella 
pneumoniae and Pseudomonas aeruginosa, while alveolar 
macrophages are apparently responsible for clearance of 
Staphylococcus aureus. Clearance studies have also been 
used to compare clearance rates of two different animal 
species when inoculated with the same bacterium. As an 
example, Lillie (58) reported that mice receiving aerosols 
of Phi cleared 76% of the inhaled organisms in 4 hours as 
compared to 90% clearance in calves. A mouse model has 
also been used as an estimator of Phi deposition for 
calves based on findings of a linear relationship of 
bacterial deposition in lungs of mice and calves exposed 
to the same bacterial aerosol (69). Rodriguez, et^  al_ (61) 
studied the effects of tracheal versus pulmonary 
deposition of Pasteurella haemolytica or Staphylococcus 
aureus on clearance in mice. Their results indicate 
bacteria are more rapidly cleared from the trachea than 
the lungs even though elimination of bacteria from the
11
entire respiratory tract was rapid. Mouse models have also 
been used to study viral-bacterial interactions in 
producing pulmonary disease. Jakab (70) studied 
interactions between Sendai virus and bacterial pathogens 
in the murine lung.
Studies such as those just mentioned in mice provide 
valuable information regarding general pulmonary defense 
mechanisms, however, attempts to develop specific 
laboratory animal models for BRDC have had limited 
success. Despite its virulence in cattle, Pasteurella 
haemolytica shows little pathogenicity for mice, guinea 
pigs, and hamsters (71). Disease has been produced in 
mice inoculated with Phi when additional substances were 
inoculated with the bacteria to increase vitulence. 
Injection of high molecular weight dextran sulfates has 
been shown to enhance infection of mice injected 
intraperitoneally with Ph (71). Smith (72) described two 
methods of creating Ph infections in mice, one by 
intraperitoneal inoculation along with mucin and the 
other by intracerebral inoculation. Evans and Wells (73) 
modified Smith's original intraperitoneal inoculation 
technique in experiments designed to study efficacy of 
Ph vaccines, however, the injection of gastric mucin was 
retained in order to produce infection. Smith (72) 
recorded results as death or survival of the mice, 
whereas, Evans and Wells (73) recorded viable numbers of
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organisms in livers as an indicator of infection. The 
mechanism of action of the gastric mucin is unclear, 
however, it has been shown to be anti-complementary in 
vitro by Lambert and Ritchley (74). Anti-complementary 
activity may not explain the virulence enhancing effect 
of mucin though, since comparison of various mucins 
revealed little correlation between anti-complementary 
activity and the ability to promote infection with 
Escherichia coli or Staphylococcus aureus (75).
Virulence of gram positive and gram negative bacteria 
has been increased by iron compounds (76-79). Chengappa, 
et al (80) injected a 2% hemoglobin preparation into mice 
along with Ph and found it to be as good an enhancer of 
virulence as gastric mucin and had the advantages over 
mucin of being easier to prepare and it does not cause 
death due to toxicity, as. mucin does. The mechanism of 
action of iron compounds in enhancing virulence may be 
related to the ability of iron to inhibit phagocytosis 
associated metabolic burst and iron's ability to 
inactivate hydrogen peroxide, both antimicrobial 
properties of normal inflammatory cells (81). According to 
Chengappa (80) Ph probably produces iron binding proteins 
which enable the organisms to utilize free circulating 
iron.
Calver, et. a (82) report that commercial mucin 
commonly contains iron and that the virulence enhancing
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effect of mucin is attributable to this iron content. Al- 
Sultan and Aitken (83) demonstrated that intraveneous 
injection of iron, as aqueous ferric ammonium citrate, 
into mice increased susceptibility to intraperitoneal 
infection with T serotypes of Pasteurella haemolytica.
All of the previously discussed mouse models for 
pasteurellosis have required the injection of some type of 
"virulence enhancer" along with the bacteria. When 
Campbell, jet a^ l (84) attempted to produce disease in 
germfree and conventionally raised mice by 
intraperitoneal, aerogenic, or oral routes of inoculation 
with Ph little or no disease was produced. Ph can be 
inactivated by mouse phagocytes and is not cytotoxic for 
mouse macrophages as it is for bovine alveolar 
macrophages (85-87) and bovine polymorphonuclear 
leukocytes (88). This may explain the failure of the 
intraperitoneal, aerogenic, and oral inoculations with 
bacteria alone to produce disease (84).
Martinez-Burnes, je_t a_l (89) studied the role of 
neutrophil recruitment in clearance of Ph and 
Staphylococcus aureus from mouse lungs inoculated by 
aerosol. The results of this study indicate Ph exposure 
causes a dramatic, significant but transient increase in 
neutrophils in the bronchoalveolar space, whereas, this 
was not true for Staphylococcus aureus exposure. The rate 
of clearance between the two genera of bacteria was the
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same, even though the cellular response was different, 
possibly indicating that each type of bacterium was 
eliminated by different cell types (89). The dramatic 
influx of neutrophils into the mouse lung following Ph 
inoculation is similar to the reaction seen in bovine 
lungs exposed to Ph (55,90) and similar to the reaction 
seen in mouse lungs following inoculation with other gram 
negative bacteria (91).
Neutrophils participate in lung injury in pathologic 
conditions induced by a variety of stimuli including 
endotoxemia, microembolization, pancreatitis and 
complement activation (92-96). The enzyme systems of 
neutrophils are capable of producing direct pulmonary 
damage and are also capable of generating chemotactic 
factors which attract additional neutrophils, thereby, 
perpetuating the damage (92). The role of neutrophils in 
pulmonary lesions following Ph inoculation has been shown 
by Slocombe, ejt al^  (97,98) in studies in which neutrophil 
depletion using hydroxyurea protected against lung injury 
up to 6 hours post inoculation. The cl i n i c a l  signs of 
lung injury were shown in these studies to be neutrophil 
mediated rather than due to direct effects of Ph. The 
mechanisms by which Pasteurella induce neutrophil 
migration into the lungs are not fully known, but may 
involve release of endotoxin which activates complement, 
damage to alveolar tissues and macrophages causing the
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release of chemotactic factors, or release of peptides 
similar to complement which attract neutrophils (98).
Neutrophil structure and granule content have been 
studied extensively in many animal species. It is 
generally agreed that there are two main classes of 
granules, the azurophilic or primary granule and the 
specific or secondary granule (99,100). The terms primary 
and secondary refer to time of production of each of the 
granule types in the developing neutrophil. The stages of 
development have been studied ultrastructural ly in several 
animal species (101-104). Criteria for each of the 
developmental stages are based on the number and types of 
cytoplasmic granules, relative abundance of ribosomes and 
polysomes, and structure and contour of the nucleus. The 
ultrastructural characteristics of the developmental 
stages with respect to granule content have been 
summarized (104) as follows:
Myeloblast- No cytoplasmic granules are present in 
the myeloblast.
Promyeloblast- This stage spans the entire phase of 
primary (azurophil) granule formation and ceases with the 
beginning of specific granule formation. Primary granules 
develop mainly from lateral extensions of the golgi and to 
a lesser extent from the concave surface of golgi.
Myelocyte- This stage begins with the production of 
secondary (specific) granules which arise from the convex
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surface of Golgi and lateral extensions of Golgi.
Metamyelocyte- Secondary granules are numerous and 
the larger primary granules which are not produced after 
the promyelocyte stage decrease with each cell division.
Band and Mature Segmented Neutrophil- No evidence for 
active granule formation can be demonstrated. Two forms of 
specific granules are present, spherical and oval to 
dumbbell shaped.
The granules of neutrophils contain several 
antibacterial substances including myeloperoxidase, 
lysozyme, lactoferrin and cationic proteins (105). 
Myeloperoxidase, an important oxygen dependent 
antimicrobial substance is found exclusively in 
azurophilic granules, lactoferrin is confined to specific 
granules. Other components of azurophilic granules include 
1 ysozyme, beta-glucuronidase, cathepsin and elastase. 
Specific granules contain lysozyme and alkaline 
phosphatase in addition to lactoferrin (100,105). Rausch, 
et al (106) studied neutrophil enzyme content from several 
different animal species including avian, laboratory 
animal and domestic species. Marked interspecies 
differences in enzyme content were found when the enzymes 
myeloperoxidase, beta-glucuronidase, lysozyme and alkaline 
phosphatase were evaluated. Cattle were found to have low 
levels of lysozyme and relatively high levels of alkaline 
phosphatase, whereas, the opposite observation was made in
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the mouse. Gennaro, et_ al^  (107) reported bovine 
neutrophils as compared to human neutrophils have lower 
content of azurophilic enzymes and virtually lack 
lysozyme.
Recently, Baggiolini, e_t aJL (108) and Gennaro, e_t al^  
(109) have reported the finding of a new third type of 
cytoplasmic granule in bovine neutrophils. The third 
granule is larger than azurophil or specific granules, 
contains lactoferrin as the only normally recognized 
granule constituent, does not contain peroxidase, and.is 
formed independently of the other two types of granules. 
The granules were found to be the exclusive stores of 
potent oxygen independent antibacterial activity, possibly 
associated with a unique group of cationic proteins (110). 
Earlier studies with human neutrophils and rabbit 
neutrophils have identified tertiary granules in those 
species (102,103), but Baggiolini, et a_l (108) state it is 
highly unlikely that one of the two types of peroxidase 
negative granules in bovine neutrophils corresponds to the 
previously described tertiary granules which are believed 
to be subpopulations of specific granules. Of the two 
peroxidase negative granules in bovine neutrophils the 
large granules do not qualify because they form at an 
intermediate stage and form the major granule component. 
The smaller, electron dense granules are excluded because 
they contain vitamin B ^ - M n d i n g  proteins,a characteristic
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marker for specific granules.
The accumulation of neutrophils and other cells at 
inflammatory sites is accomplished through mechanisms 
which are only partially understood. One mechanism by 
which phagocytes accumulate at inflammatory sites is by 
chemotaxis, the directed migration of cells in response 
to a gradient of a chemoattractant substrate (111). This 
directed migration of cells requires at least the 
following events: 1) recognition of chemical signals by 
the cell membrane, 2) activation of energy-forming 
processes within the cell, and 3) the translation of this 
energy by cytostructural elements into directed movement. 
Chemotactic factors have been investigated biochemically 
in vitro by various quantitative techniques. Pike and 
Snydermann (111) list four categories of chemotactic 
factors for which there is evidence of a biological role 
as well as the jin vitro evidence : 1) complement derived 
factors, 2) cellular derived factors, 3) bacterial 
factors and synthetic formylated peptides, and 4) lipid 
associated factors. Of these four categories the lipid 
associated factors are of particular importance to this 
dissertation and, therefore, will be discussed.
The eicosanoids are the oxygenated, biologically 
active derivatives of the 20-carbon essential fatty acid 
arachidonate and include prostaglandins, thromboxane, 
prostacyclin, 1 eukotrienes, and other hydroxy acids (112).
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Recent articles have reviewed the biosynthesis and 
biologic activity of these compounds (112-116). Marcus 
(112) classified eicosanoids as "autacoids, substances 
which are evanescent and exert their effects locally in 
the microenvironment of the tissues where they were 
generated.” The eicosanoids are not stored in cells and 
must be newly synthesized from their precursor, 
arachidonic acid (AA), in response to perturbation. The 
release of AA from membrane phospholipids through the 
activation of phospholipase A 2 is generally thought to be 
the rate limiting step for synthesis of eicosanoids (114-). 
Released arachidonate may leave the cell and be 
metabolized by another cell or it may be bound by plasma 
albumin (112). The arachidonate can be enzymatically 
oxygenated by a particulate cyclooxygenase and/or a 
cytoplasmic lipoxygenase to form intermediate components 
and ultimately prostaglandins, thromboxanes, hydroxy acid 
and leukotrienes (117,118). The final products formed will 
depend on the type of converting enzyme present in a 
particular tissue. Products of both the cyclooxygenase and 
lipoxygenase pathways of AA metabolism are important 
mediators of inflammation through a variety of actions on 
smooth muscle, vascular endothelial cells, platelets, and 
inflammatory cells.
The cyclooxygenase pathway gives rise to 
prostaglandins and thromboxanes as final biologically
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active products (112, 114, 115). Thromboxane is an 
unstable, yet biologically active, by-product of the 
cyclooxygenase pathway which causes irreversible platelet 
aggregation, contraction of vascular smooth muscle, and 
contraction of tracheal smooth muscle (119-122). Several 
prostaglandins are produced via the cyclooxygenase 
pathway. Prostaglandins exhibit antagonistic effects in 
the inflammatory response as shown by Chensue, e_t a_l (123) 
and Kunkel, et^  aJL (124) by studies in which prostaglandin 
E-^  suppressed development of pulmonary granulomas in mice 
following embolization of Schistosoma mansoni eggs and 
prostaglandin F 2 _a ^piia potentiated the granuloma 
formation. Goldstein, et^  a_l (125) had earlier reported 
that prostaglandin E-^  stimulates the accumulation of cAMP 
in inflammatory cells and this action inhibits the release 
of mediators of inflammation. In contrast, prostaglandin 
^2-alpha increases cGMP which enhances release of 
inflammatory mediators from cells.
The lipoxygenase pathway of AA metabolism gives rise 
to hydroxy acids and the leukotrienes (LT), a group of 
acyclic eicosanoids. The name leukotriene comes from the 
fact that they were first isolated from leukocytes and 
that they contain a conjugated triene, three alternating 
double bonds (126). Using the nomenclature devised by 
Samuelsson and Hammarstrom (127) numerical subscripts 
refer to the total number of double bonds and letters
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refer to the substituents of the pathway in alphabetic 
order. Leukotrienes A^, B^, C^, D^, E^, and arise from 
the 5-lipoxygenase pathway, although leukotrienes may 
arise through the 12- and 15-lipoxygenase pathways also 
(117). Slow reacting substance of anaphylaxis (SRS-A) was 
originally recovered from perfused lung following 
injection of cobra venom (128), however, the structure was 
unknown. SRS-A is now known to consist of a mixture of 
leukotrienes, LTC^ and its metabolites, LTD^ and LTE^. The 
major biological actions of LTC^, LTD^, and LTE^ include 
bronchoconstriction, reduced expiratory flow in the 
pulmonary system, vasoconstriction of coronary circulation 
and terminal arterioles in other tissues (112).
Another biologically active product of the 
lipoxygenase pathway is leukotriene B^. Leukotriene B^ is 
generated by neutrophils (92,129-132) and macrophages 
(133) as we l l  as other c e l l s  (116). While several of the 
hydroxyeicosatetraeinoic acid (HETE’s) of AA, e.g. 5-HETE, 
8-HETE, 9-HETE, 12-HETE, and 15-HETE, attract human 
neutrophils (134), LTB^ is the strongest chemotactic agent 
for neutrophils of the lipoxygenase products 
(92,117,129,130,135-137). In addition to its effect as a 
chemotactic agent for neutrophils, LTB^ also induces 
neutrophil degranulation (92,129,138-140). The 
degranulating effect of LTB^ is weaker than that of other 
chemotactic agents such as N-formy1-methiony1-leucy1-
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phenylalanine (FMLP) and the complement fragment C5a 
(132). These properties of neutrophils and LTB^, e.g. that 
neutrophils release LTB^ during degranulation and that 
LTB^ is chemotactic for neutrophils and induces neutrophil 
degranulation, provide the basis for self-perpetuating 
tissue damage once an inflammatory reaction is started. 
Such a condition may exist in the bovine lung following 
Pasteurella haemolytica infection.
Numerous drugs used experimentally and clinically 
inhibit the synthesis of AA metabolites by inhibiting one 
or more steps in the enzymatic pathways. Blockage of AA 
production from phospholipids is the first point in the 
pathway at which anti-inflammatory compounds can be used 
and this is the point at which corticosteroids exert their 
effects (112,141). Research in recent years has been 
concentrated more toward the development of non-steroidal 
compounds which block one or both of the pathways of AA 
metabolism rather than blocking the production of AA. Most 
of the non-steroidal anti-inflammatory drugs (NSAID's) are 
selective inhibitors of cyclooxygenase and, therefore, 
prevent formation of prostaglandins, thromboxanes and 
endoperoxides (142). Non-steroidal anti-inflammatory drugs 
include indomethacin, naproxen, TA-60, phenylbutazone, 
ibuprofen, and aspirin (112,141,143,144). These anti­
inflammatory drugs have traditionally been thought to 
prevent inflammation solely through their inhibition of
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prostaglandin synthesis. Recent studies, however, have 
found that many of these drugs also have inhibitory 
actions on neutrophil function which is not related to 
their effect on the cyclooxygenase enzyme (141,145-149).
Several drugs such as BW 755c and timegadine are 
inhibitory to both the cyclooxygenase and lipoxygenase 
pathways (124,143). Since several lipoxygenases are 
involved in the oxidation of arachidonate the site of 
oxidation (5, 12, or 15) will depend on the specificity of 
the lipoxygenase. Consequently, there is no single 
lipoxygenase inhibitor, rather there are inhibitors of 5-, 
12-, or 15-lipoxygenase (141). Selective lipoxygenase 
inhibitors include nordihydroguaiaretic acid (NDGA), 
nafazatrora, benzoquinone, pyrazolecarboxylie acid 
hydrazides, and eicosatriynoic acid (ETI) (124,143,ISO- 
152). Even though studies have shown the lipoxygenase 
inhibitory actions of these agents and these actions were 
thought to be selective, recent reports are finding that 
those actions may not be as specific as originally 
thought, as was found with the cyclooxygenase 
inhibitors (153). '
CHAPTER II
Induction of Pneumonic Pasteurellosis in Mice by 
Intrabronchial Inoculation of Pasteurella haemolytica 
serotype 1
ABSTRACT
Pasteurella haemolytica serotype 1 inoculated 
intrabronchially into male, outbred Swiss Webster mice 
produced dose dependant pulmonary lesions. Five
4 o
exponential di l u t i o n s  ranging from 5 X 10 to 5 X 10 
colony forming units of Pasteurella haemolytica serotype 
1 were inoculated into five groups of mice. Mice were 
killed by cervical dislocation 24 hours post inoculation. 
Pulmonary lesions occurred in mice of all five groups. 
Five X 10^ colony forming units was the minimum dose 
which produced consistent lesions. Flooding of 
interalveolar septa and alveoli by edema fluid, fibrin, 
neutrophils and macrophages, focal parenchymal necrosis, 
and suppurative bronchiolitis were observed 
microscopically. It was concluded that outbred Swiss 
Webster mice could be used as an economical model for the 
study of selected disease mechanisms and for preliminary
24
25
trials of potential therapeutic agents for bovine 
pneumonic pasteurel1 osis.
INTRODUCTION
Bovine respiratory disease is one of the major 
causes of economic loss to the cattle industry (1). A 
variety of infectious agents has been incriminated as the 
etiology of bovine respiratory disease. Pasteurel la 
haemolytica (Ph) is the most frequently isolated organism 
from field cases (12,23,24). This organism causes a 
severe fibrinous pneumonia in cattle. An experimental 
model of bovine pneumonic pasteurellosis has been 
developed via intrabronchial inoculation of Pasteurella 
haemolytica serotype 1 (Phi) into the caudal lung lobe of 
calves using an indwelling surgically placed catheter 
(55,56,57). However, research using cattle is slow and 
often prohibitively expensive. This chapter describes the 
induction of pneumonia in outbred Swiss Webster mice by 
intrabronchial inoculation of Phi.
MATERIALS AND METHODS
Animals. Male outbred Swiss Webster mice weighing 
18-24 grams were obtained from a commercial supplier. 
Mice were housed 6 per cage and fed commercial mouse chow 
and water ad libitum. No procedures were performed on 
mice for a period of at least 7 days after arrival from 
the supplier.
Bacteria. Pasteurella haemolytica serotype 1 (Phi)
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for mouse inoculation were obtained from 18-24 hour 
cultures of a lyophile prepared from organisms isolated 
from a field case of bovine pasteurellosis. The lyophile 
was streaked for isolation onto brain heart infusion agar 
enriched with 1% yeast extract, 5% bovine blood, and 10% 
horse serum and was incubated at 37 degrees C. The 
following day a suspension of colonies was streaked onto 
the enrichment agar. The agar was incubated at 37 degrees 
C for 18-24 hours and the Phi were suspended in 
Dulbecco's phosphate buffered saline, pH 7.2, to give an 
optical density of 0.28 at 650 nanometers. Five
lx  8exponential dilutions ranging from 5 X 10 to 5 X 10 
colony forming units of Phi were made from this 
suspension.
Inoculation. Mice were divided into five groups of 
6-8 mice and each group was inoculated with one of the 
five exponental dilutions of Phi. The mice were 
anesthetized by intraperitoneal injection with 2% sodium 
thiamylal (Surital, Parke-Davis). Mid-cervical 
tracheostomies were performed and 0.1 ml of the 
appropriate dose of Phi was inoculated by passing a 
flexible plastic tube down the trachea to the lung. 
Surgical incisions were not sutured to prevent tracheal 
collapse by trapped air and edema fluid in subcutaneous 
tissues.
Evaluation. At 24 hours post inoculation mice were
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euthanized by cervical dislocation and routine necropsies 
were performed. The lungs were fixed by vascular and 
airway perfusion with 4% formaldehyde 1% glutaraldehyde 
(4F1G). Following fixation, lungs were sliced serially at 
1 mm intervals and samples of lung were processed for 
examination by light microscopy and transmission electron 
microscopy. Sections of liver, spleen and kidney from 
each animal were also processed for examination by light 
microscopy. Sections for light microscopy were embedded 
in paraffin, sectioned at 6 microns and stained with 
hematoxylin and eosin.
After fixation in 4F1G lung samples for electron 
microscopy were washed in 0.1 M sodium cacodylate 
containing 5% sucrose, post-fixed with 1% osmium tetroxide 
in 0.1 M sodium cacodylate, and dehydrated through an 
ascending alcohol series (50-100%). Samples were then 
processed through propylene oxide followed by a series of 
propylene oxide and epon-araldite in the following 
ratios: propylene oxide to epon-araldite, 75%:25%,
50%:50%, 25%:75%. Infiltration and embedding were done in
epon-araldite. Thin sections were cut on an 
ultramicrotome (Sorvall MT 5000, Ivan Sorvall, Inc. 
Norwalk, CT), were stained with uranyl acetate and lead 
citrate, and were examined on a transmission electron 
microscope (Zeiss EM 10, Carl Zeiss, Inc., New York, NY).
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RESULTS
Pulmonary lesions were produced in all five dosage 
groups with the degree of severity of lesions increasing 
as the exponential dose of bacteria increased. The 
minimum dose which produced consistent pulmonary lesions 
was 5 X 10^ colony forming units of Phi. Gross lesions 
varied from focal dark red to black discoloration of 
pleural and cut surfaces of inoculated lung lobes to 
discoloration of entire lobes. In some mice gross lesions 
were not detectable even though microscopic lesions were 
observed. Summaries of microscopic lesions by dosage 
group are as follows:
5 X 10^ dose. Eight mice were inoculated in this 
group and all. lived 24 hours post inoculation. Lesions 
were minimal to mild and consisted of scattered to 
diffuse infiltration of alveolar septa by neutrophils and 
macrophages, scattered hemorrhages, and focal 
accumulations of neutrophils in alveoli (Figure 1).
5 X 10^ dose. Six mice were inoculated and all 
lived 24 hours post inoculation. Lesions were moderate 
with increased neutrophil infiltration and edema 
accumulation in alveoli (Figure 2). Formation of fibrin 
thrombi within capillaries, accummulation of edema fluid 
in the interstitium and alveoli and exudation of 
neutrophils into bronchial and bronchiolar lumens 
occurred.
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Fig. 1: 10^ Phi dose. Mild neutrophil infiltration of 
alveoli and interstitium.
Fig. 2: 10^ Phi dose. Neutrophil infiltration and edema 
accumulation in alveoli.
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5 X 10® dose. Eight mice were inoculated, seven 
lived 24 hours and one died 7.5 hours post inoculation. 
Lesions in this group were similar to the previous group 
in severity and nature with the exception of more fibrin 
exudation in the interstitium and into alveoli and 
widespread bronchiolitis, characterized by infiltration 
of walls by inflammatory cells, focal denudement of 
bronchiolar epithelium and filling of lumens by 
neutrophils (Figure 3).
5 X 107 dose. Seven mice were inoculated, five 
lived 24 hours, one died 6.5 hours and one died 7.5 hours 
post inoculation. Formation of fibrin thrombi within 
capillaries, focal parenchymal necrosis, and flooding of 
the interstitium and alveoli by edema fluid, fibrin, 
neutrophils and macrophages characterized the lesions 
produced at this dosage level (Figures 4). Exudation of 
neutrophils into bronchi and bronchioles occurred as 
described in the previous group.
5 X 10® dose. Six mice were inoculated, five lived 
24 hours and one died 12-22 hours post inoculation. 
Lesions were similar to the previous group but more 
severe in nature. Parenchymal necrosis was widespread 
and bronchial exudates were more prominent in this group 
(Figure 5).
Ultrastructural ly, lesions were seen in all five 
dosage groups, however, all lungs within the lowest
Fig. 3: 10^ Phi dose. Neutrophil infiltration of alveoli 
and filling of bronchiolar lumen by neutrophils.
Fig. 4: 10^ Phi dose. Flooding of interstitium and 
alveoli by edema, fibrin, neutrophils, and macrophages.
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Fig. 5: 10 Phi dose. Widespread parenchymal necrosis, 
flooding of interstitium and alveoli by neutrophils, 
btonchiolar exudate.
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dosage group did not contain lesions. Ultrastructural 
lesions are as follows:
5 X 10^ dose. Lesions varied from animal to animal 
in this group. In some lungs no changes were apparent. In 
other lungs alveolar septa were widened by congestion and 
there was leakage of proteinaceous fluid into alveoli and 
infiltration of neutrophils into alveolar spaces. 
Neutrophils present in alveoli frequently had smooth 
cytoplasmic membranes with few or no filapodia 
(Figure 6).
5 X 105 dose. Leakage of fluid into a l v e o l i  and 
neutrophil infiltration were prominent changes seen in 
lungs of mice in this group (Figure 7). Blood vessels 
were congested and there was sludging of neutrophils in 
many blood vessels.
5 X 10® dose. Interalveolar septa were slightly 
widened by the accumulation of fluid. Alveoli contained 
hemorrhage and cell debris in addition to neutrophils as 
seen in previous groups (Figure 8).
5 X 107 dose. Marked leakage of proteinaceous fluid 
and infiltration of neutrophils into alveoli 
characterized lesions in this group (Figure 9). Blood 
vessels in alveolar septa were often congested.
Occasional 1 ly, neutrophils contained degenerated bacteria 
within phagocytic vacuoles.
5 X 10® dose. Numerous bacteria (Figure 10) were
Fig. 6: 10^ Phi dose. TEM of lung. Neutrophils with no 
filapodia and few granules in alveolar lumen. Bar = 1 um.
Fig. 7: 105 Phi dose. TEM of lung. Leakage of 
proteinaceous fluid and neutrophil infiltration of 
alveoli. Bar = 4 um.
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Fig. 8: 10^ Phi dose. TEM of lung. Neutrophils, 
macrophage, and hemorrhage in alveoli. Bar = 1 um.
Fig. 9: 107 Phi dose. TEM of lung. Leakage of 
proteinaceous fluid and infiltration of alveoli by 
neutrophils. Bar = 1 um.
36
Fig. 10: 10® Phi dose. TEM of lung. Bacteria in alveolar 
lumina (Arrows). Bar = 0.5 um.
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present within phagocytic cells and free in alveoli. 
Alveoli were flooded with fluid and phagocytic cells 
including neutrophils and macrophages. Interalveolar 
septa were widened by accumulation of fluid and 
proliferation of macrophages.
DISCUSSION
While experimental bovine models have been used 
to study bovine pneumonic pasteurellosis (24,51,53,55), 
attempts to develop laboratory animal models have had 
limited success. Aerosol, oral and intraperitoneal Phi 
inoculation in conventionally raised and germfree mice 
produced little or no disease (84). Disease has been 
produced in mice by inoculating additional substances 
such as gastric mucin (73) or hemoglobin (80) to enhance 
the virulence of the organism. In addition, injection of 
high molecular weight dextran sulfates has been shown to 
enhance infection of mice injected intraperitoneally with 
Ph (71).
In this study pneumonic lesions were produced in 
outbred Swiss Webster mice via intrabronchial inoculation 
of Phi alone. Microscopic lesions produced are similar to 
those produced in the bovine following Phi inoculation. 
Neutrophil influx into the pulmonary interstitium and 
alveoli, formation of fibrin thrombi, accumulation of 
edema fluid and parenchymal necrosis are prominent 
features in both species.
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Using this technique the mouse may be used as an 
economical model for at least some aspects of bovine 
pneumonic pasteurel1 osis. This model could provide an 
economical means for studying disease pathogenesis and 
probable effectiveness of preventive and therapeutic 
agents for pneumonic pasteurellosis prior to evaluation 
in the bovine species.
CHAPTER III
Temporal Evolution of Lesions Produced by Intrabronchial 
Inoculation of Pasteurella haemolytica in Mice
ABSTRACT
Pasteurella haemolytica inoculated intrabronchially 
into male, outbred Swiss Webster mice produced pulmonary 
lesions as early as four hours post inoculation. Five 
groups of mice were inoculated with 5 X 10^ colony 
forming units of Pasteurella haemolytica serotype 1. One 
group of mice was killed by cervical dislocation at each 
of the following time points post inoculation: 2 hours, 4 
hours, 8 hours, 12 hours, and 24 hours. Lesions were seen 
in the lungs of mice from each of the five groups, 
however, 4 hours was the minimum time required for 
neutrophils to play a significant role in lesion 
development. Lesion severity did not significantly change 
from 4 to 8 hours post inoculation, however, severity 
increased at 12 hours post inoculation. At 2 hours post 
inoculation lesions were minimal. Microscopic lesions 
included accumulation of edema in the interstitium and 
alveoli, fibrin exudation, focal parenchymal necrosis, 
and infiltration of the interstitium and alveoli by
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neutrophils and macrophages. It was concluded that 
following intrabronchial inoculation with 5 X 10^ colony 
forming units of Pasteurella haemolytica in mice a 
minimum of 4 hours is required before appreciable 
neutrophil influx into the lung occurs.
INTRODUCTION
Pasteurella haemolytica is the most frequently 
isolated organism from field cases of the bovine 
respiratory disease complex (12,23,24). Experimental 
models of pneumonic pasteurellosis have been achieved 
through the use of a variety of inoculation techniques in 
the bovine (22,34,35,37,50,51,52,54,55). These models 
have permitted significant advances to be made in 
understanding the relationship of various etiologic 
factors and pathogenesis of the bovine respiratory 
disease complex. However, the use of the bovine species 
in experimental studies is expensive and results are 
often slowly obtained. For these reasons, there is 
considerable interest in the use of laboratory animal 
species as models for bovine respiratory disease.
Pasteurella haemolytica shows little pathogenicity 
for mice, guinea pigs, and hamsters (71). Disease has 
been produced in mice inoculated with Pasteurella 
haemolytica serotype 1 (Phi) when additional substances 
were inoculated to increase virulence (71,72,73,80). 
Campbell, e_t aJL^  (84) produced little or no disease in
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conventionally raised and germfree mice by 
intraperitoneal, aerogenic, or oral routes of 
inoculation. The present study was designed to evaluate 
the effect of intrabronchial inoculation of Phi in mice 
at various time points (2-24 hours) post inoculation. 
MATERIALS AND METHODS
Animals. All mice were obtained from a commercial 
supplier. Male, outbred Swiss Webster mice weighing 18-24 
grams were used in all groups. Mice were housed 6 per 
cage and no procedures were performed on mice for a 
minimum of 7 days after they were received from the 
supplier. Mice were fed commercial mouse chow and water 
ad libitum.
Bacteria. Pasteurella haemolytica for mouse 
inoculation were obtained from a single lyophile prepared 
from a field case of bovine pneumonic pasteurellosis. 
Eighteen to twenty-four hour cultures of the lyophile 
were streaked onto brain heart infusion agar enriched 
with 1% yeast extract, 5% bovine blood, and 10% horse 
serum and were incubated at 37 degrees C. The following 
day a suspension of colonies, was streaked onto the 
enrichment agar. The agar was incubated at 37 degrees C 
for 18-24 hours and the Phi were suspended in Dulbecco’s 
phosphate buffered saline, pH 7.2, to give an optical 
density of 0.26 at 650 nanometers. Mice were inoculated 
with 5 X 10^ colony forming units of Phi.
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Inoculation. Mice were divided into five groups. 
After anesthesia by intraperitoneal injection with 2% 
sodium thiamylal (Surital, Parke-Davis), mid-cervical 
tracheostomies were performed and mice were inoculated by 
passing a flexible plastic tube down the trachea to the 
lung. Each mouse received 0.1 ml of 5 X 10^ colony 
forming units of Phi. Surgical incisions of the skin 
were not sutured to prevent tracheal collapse by trapped 
air and edema in subcutaneous tissues.
Evaluation. One group of mice was killed by 
cervical dislocation at 2, 4, 8, 12, and 24 hours post 
inoculation. Routine necropsies were performed and lungs 
were fixed by vascular and airway perfusion with 4% 
formaldehyde 1% glutaraldhyde (4F1G). Following fixation 
for a minimum of 48 hours lungs were sliced at 1 mm 
intervals and samples were processed for examination by 
light microscopy and electron microscopy. For light 
microscopy tissues were embedded in paraffin and 
sectioned at 6 microns. Tissue sections were stained with 
hematoxylin and eosin.
Lung specimens for transmission electron microscopy 
were washed in 0.1 M sodium cacodylate containing 5% 
sucrose, post-fixed with 1% osmium tetroxide in 0.1 M 
sodium cacodylate, and dehydrated through an ascending 
alcohol series (50-100%). Samples were then processed 
through 100% propylene oxide followed by a series of
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propylene oxide and epon-araldite in the following 
ratios: propylene oxide to epon-araldite, 75%:25%, 
50%:50%, 25%:75%. Samples were infiltrated and embedded 
in epon-araldite. Thin sections were cut on an 
ultramicrotome (Sorvall MT 5000, Ivan Sorvall, Inc., 
Norwalk, CT.), were stained with uranyl acetate and lead 
citrate, and were examined on a transmission electron 
microscope (Zeiss EM 10, Carl Zeiss,' Inc., New York, NY). 
RESULTS
Gross lesions consisted of dark red to black 
discoloration of all or part of lung lobes. Microscopic 
lesions could not always be correlated with the gross 
changes because microscopic lesions were seen in some 
lungs which appeared normal grossly. Within specific 
groups there was often considerable variation in the 
severty of lesions seen. Summaries of microscopic lesions 
by group are as follows:
2 hours post inoculation. Six mice were inoculated; 
five lived until the 2 hour k i l l  time and one died at 1.5 
hours post inoculation. Lesions were inconsistent ranging 
from essentially normal lungs to multifocal mild 
neutrophil infiltration of the interstitium and alveoli, 
congestion, hemorrhage, and edema accumulation. In some 
lungs mild, diffuse fibrin exudation was present in 
alveoli (Figure 1). Significant neutrophil infiltration 
occurred in lungs of only two mice, however, sludging of
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Fig. Is 2 hr P.I.: Mild fibrin exudation into 
alveoli.
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neutrophils in septal blood vessels was seen in other 
mice.
4 hours post inoculation. Five mice were inoculated 
and all lived until the 4 hour kill time. Lesions 
consisted of patchy alveolar edema, fibrin exudation in 
the interstitium, mild alveolar hemorrhage, and mild to 
marked neutrophil infiltration of the interstitium and 
alveoli. In addition there was focal necrosis of 
bronchiolar walls with infiltration of the walls by 
neutrophils (Figure, 2). Lungs from two mice had minimal 
lesions.
8 hours post inoculation. Ten mice were inoculated; 
six lived 8 hours and 4 died 3-3.5 hours post inoculation 
Severity of lesions in this group was similar to the 4 
hour group. Lesions were more widespread in some lungs, 
sometimes involving entire lobes. The most consistent 
lesions were multifocal to diffuse mild neutrophil 
infiltration of the interstitium and alveoli, scattered 
hemorrhages, congestion of septal capillaries, and 
interstitial edema accumulation (Figure 3). The most 
severe lesions consisted of diffuse infiltration of the 
interstitium by neutrophils and macrophages, formation of 
fibrin thrombi, and exudation of fibrin into the septa.
12 hours post inoculation. Nine mice were 
inoculated; six l i v e d  12 hours and 3 died 5-11 hours post 
inoculation. Lesion components were similar to the
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Fig. 2: 4 hr P.I.: Neutrophil infiltration into alveoli 
and bronchiole.
Fig. 3: 8 hr P.I.: Mild neutrophil infiltration of 
interstitium and alveoli; edema.
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previous groups with congestion, multifocal alveolar 
hemorrhages, fibrin exudation, and infiltration of the 
interstitium and alveoli by neutrophils the predominate 
features. In addition, in some lungs there was focal 
parenchymal necrosis with severe neutrophil influx, fibrin 
exudation and edema accumulation present (Figure 4).
24 hours post inoculation. Eight mice were 
inoculated; six lived 24 hours and 2 died 3 hours post 
inoculation. Lesions ranged from multifocal, mild 
infiltration of alveoli and interstitium by neutrophils, 
scattered hemorrhages, congestion, fibrin exudation, and 
edema (Figure 5) to diffuse, moderate neutrophil and 
macrophage infiltration into interstitium and alveoli, 
fibrin thrombi formation and fibrin exudation.
Occasionally bronchiolar walls were disrupted and there 
was loss of bronchiolar epithelium, infiltration of the 
walls by neutrophils and fibrin exudation into 
bronchiolar lumens.
Ultrastructural changes were seen in mice of all 
five groups. Ultrastructural changes by group are 
summarized as follows:
2 hours post inoculation. Occasionally neutrophils 
were seen in alveoli, however, in most sections minimal 
lesions were present. Alveolar septa were usually thin 
and alveoli contained primarily alveolar macrophages. In 
some sections there was hemorrhage and leakage of
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Fig. 4: 12 hr P.I.: Focal parenchymal necrosis, 
neutrophil infiltration, fibrin exudation, edema 
accumulation.
Fig. 5: 24 hr P.I.: Mild infiltration of alveoli and 
interstitium by neutrophils; interstitial edema.
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proteinaceous fluid into alveoli (Figure 6).
4 hours post inoculation. The most prominent 
ultrastructural change at this time point was marked 
sludging of neutrophils in septal blood vessels (Figure 7) 
and adherence of neutrophils to vascular intima.
Alveoli contained hemorrhages and a few neutrophils. In 
addition, there was proliferation of macrophages in the 
interstitium.
8 hours post inoculation. Alveolar septa were 
frequently widened by congestion and edema accumulation. 
Sludging and adherence of neutrophils in blood vessels 
was a common change seen (Figure 8). In some sections 
there was leakage of proteinaceous fluid into alveoli and 
infiltration of alveoli by neutrophils.
12 hours post inoculation. Alveolar septa were 
widened by congestion of blood vessels and proliferation 
of interstitial macrophages. Alveoli contained 
hemorrhage, macrophages, neutrophils (Figure 9).
Occasinally there was accumulation of proteinaceous fluid 
in alveoli.
24 hours post inoculation. Neutrophils, some with 
phagocytic vacoules, infiltrated alveoli. Phagocytic 
vacoules of some cells contained degenerated bacteria 
(Figure 10). Many neutrophils contained few granules and 
had smooth cell membranes with few or no pseudopodia.
Fig. 6: 2 hr P.I.: TE M  of lung. Hemorrhage and 
proteinaceous fluid in alveoli. Bar = 2 um.
Fig. 7: 4 hr P.I.: TEM of lung. Sludging of neutrophils
in blood vessels (arrow). Bar = 2 um.
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Fig. 8: 8 hr P.I.: TEM of lung. Sludging of neutrophils
in blood vessel. Bar = 1 um.
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10
Fig. 9: 12 hr P.I.: TEM of lung. Hemorrhage, macrophages, 
and neutrophil in alveoli. Bar = 2 um.
Fig. 10: 24 hr P.I.: TEM of lung. Neutrophil with
phagocytized degenerate bacterium (arrow). Bar = 0.5 um.
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DISCUSSION
Even though microscopic lesions were seen in lungs 
of mice from each of the five groups, there was 
considerable inconsistency with respect to development of 
lesions and severity of lesions seen. The 4 hour post 
inoculation group was the first group to show significant 
neutrophil involvement as a lesion component. The degree 
of severity between groups was expected to progress 
stepwise from the earliest time point to the latest time 
point, however, this was not always the case. Differences 
in the degree of severity of lesions between the 4 hour 
and 8 hour groups was not appreciable. Differences were 
apparent between the 8 hour and 12 hour groups, even 
though there were individual animals in the 12 hour group 
with lesions less severe than some animals in the 8 hour 
group. Lesions in the 24 hour group were no more severe 
than those in the 12 hour group.
The lack of consistency of lesion development within 
groups and between groups may reflect differences in 
the background of the outbred mice. The organism the mice 
were inoculated with was derived from a field case of 
bovine pneumonic pasteurellosis. The fact that the 
organism had not been passed through mice may have 
contributed to the variable results since the organism 
normally has little pathogenicity for mice, guinea pigs, 
and hamsters (71).
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Even though results were variable it was apparent 
that 4 hours was the minimum time required for 
neutrophils to become a significant factor in pulmonary 
lesion development following intrabronchial inoculation 
with Phi. This time point may then be a critical point to 
consider in other studies designed to evaluate the 
effects of various pharmacological agents on neutrophil 
dependent pulmonary lesion development.
CHAPTER IV
The Use of Inhibitors of Arachidonic Acid Metabolism to 
Modulate Pulmonary Lesions Produced by Intrabronchial 
Inoculation with Pasteurella haemolytica in Mice
ABSTRACT
Outbred Swiss Webster mice were intrabronchial ly 
inoculated with one of three inocula: Pasteurel la 
haemolytica serotype 1, carbon particles, or saline. Each 
inoculation group was subdivided into 4 pretreatraent 
groups: no pretreatment, Indomethacin pretreatment 
(cyclooxygenase inhibitor), NDGA pretreatraent 
(lipoxygenase inhibitor), or hydroxyurea pretreatraent 
(neutrophil depletion controls). Mice were killed at 4 or 
24 hours post inoculation and pulmonary tissues were 
examined by light and electron microscopy, pulmonary 
lavage fluid and serum enzyme levels (elastase, beta- 
glucuronidase, myeloperoxidase) were evaluated, and WBC 
and lavage cell counts were performed.
No significant differences were seen within PBS 
inoculated control groups or C inoculated phagocytosis 
control groups at the morphologic level. NDGA pretreated 
Phi inoculated mice had less severe pulmonary lesions
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than non-pretreated or Indomethacin pretreated Phi 
Inoculated mice. Lavage enzyme levels were not 
statistically different, however, there was a tendency 
for NDGA pretreated Phi inoculated mice to have lower 
activity per lavage cell than Indomethacin or non- . 
pretreated mice at 4 hours.
INTRODUCTION
Neutrophils participate in lung injury in pathologic 
conditions induced by a variety of stimuli including 
endotoxemia, microembolization, pancreatitis and 
complement activation (92-96) in addition to bacterial 
infection. Contents of neutrophil granules are capable of 
causing direct damage to pulmonary tissues and are also 
capable of attracting additional neutrophils to 
inflammatory sites, thereby, perpetuating the process.
The role of neutrophils in pulmonary lesions induced by 
experimental Pasteurella haemolytica infection has been 
demonstrated in studies in which neutrophil depletion was 
achieved by pretreatment with hydroxyurea (97,98). The 
mechanisms by which Pasteurella induce neutrophil 
migration into the lung are not fully known, but may 
involve the release of endotoxin which activates 
complement, damage to alveolar tissues and macrophages 
causing the release of chemotactic factors, or release of 
peptides similar to complement which attract neutrophils 
(98).
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Damage to cell membranes causes the release of 
arachidonic acid from membrane phospholipids. Arachidonic 
acid is subsequently acted upon by either cyclooxygenase 
or lipoxygenases to form eicosanoids, biologically active 
compounds including prostaglandins, thromboxanes, 
leukotrienes, and other hydroxy acids (112,114). 
Leukotriene (LTB^) is a product of the lipoxygenase 
pathway of arachidonic acid metabolism which is a strong 
chemotactic agent for neutrophils, (92,117,129,130,135- 
137), and an inducer of neutrophil degranulation 
(92,129,138-140). LTB^ is generated by neutrophils (92, 
129-132) and macrophages (133) as well as other cells 
(116). Inhibition of LTB^ production with specific 
lipoxygenase inhibitors such as nordihydroguaiaretic acid 
(NDGA) should decrease neutrophil induced pulmonary 
damage following Pasteurella haemolytica infection.
Prostaglandins, products of the cyclooxygenase 
pathway of arachidonic acid metabolism, have been shown 
to have antagonistic effects on the inflammatory response 
(123-125). Therefore, inhibition of the cyclooxygenase 
pathway with compounds such as indomethacin (Indo) should 
have no effect on neutrophil induced pulmonary damage.
This experiment was designed to evaluate the effects 
of NDGA and indomethacin in modulation of pulmonary 
lesions following intrabronchial inoculation with 
Pasteurella haemolytica serotype 1 (Phi). Animals
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depleted of neutrophils with hydroxyurea served as 
neutropenic controls. Mice were used as an experimental 
laboratory animal model for bovine pneumonic 
pasteurellosis as described in previous chapters. 
MATERIALS AND METHODS
Animals: Male, outbred Swiss Webster mice weighing 
18-24 grams were used in all studies. The mice were 
obtained from a commercial supplier. Mice were fed 
commercial mouse chow and were housed six per cage. No 
procedures were performed on the mice for a minimum of 
seven days after they were received from the supplier.
Inoculum: Mice were inoculated with one of three 
inocula: Phi, saline (PBS), or carbon particles (C). 
Animals inoculated with carbon served as phagocytosis 
controls. Pasteurella haemolytica isolated from a field 
case of bovine pneumonic pasteurellosis were mouse 
adapted by intraperitoneally injecting the organism into 
mice, killing the mice at 24 hours post inoculation and 
culturing the organisms from internal organs. Two 
passages through mice were done and pure cultures from 
the last passage were lyophilized. These lyophiles served 
as the source of organisms for all studies. For each 
inoculation one lyophile was thawed and streaked onto 
brain heart infusion agar enriched with 1% yeast extract, 
5% bovine blood, and 10 % horse serum and were incubated 
at 37 degrees C. The next day a suspension of colonies
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was streaked onto the enrichment agar. The agar was 
incubated at 37 degrees C for 18-24 hours and the Phi 
were suspended in Dulbecco's phosphate buffered saline to 
give an optical density of 0.26 at 650 nanometers. 
Titration was done to reach a final inoculum containing 
7.5 X 10® colony forming units per ml. One tenth of a ml 
of this inoculum was used to achieve a dose of 7.5 X 10^ 
colony forming units per mouse.
Carbon (C) for inoculation as a phagocytosis control 
was obtained from India ink (Pelikan, Hannover, Germany) 
as previously reported (63,64). India ink was diluted 
1:10 with distilled water and was filtered through a #2 
Whatman filter. The filtered fluid was filtered through a 
0.45 micron millipore filter to collect carbon particles 
less than 0.45 microns in diameter. Carbon particles were 
centrifuged at 9000 g, were weighed, and were resuspended 
in dis t i l l e d  water to give 40 mg carbon per ml. This 
final preparation was autoclaved to achieve 
sterilization. Mice were inoculated intrabronchial ly with 
0.1 ml of the carbon solution for a final dose of 4 mg 
carbon per mouse.
Control animals were inoculated with 0.1 ml of 
Dulbecco's phosphate buffered saline, the same solution 
into which bacteria for inoculation were suspended.
Inoculations were made after mice were anesthetized 
with intraperitoneal injection with 2% sodium thiamylal
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(Surital, Parke-Davis). Midcervical tracheostomies were 
done and a flexible plastic tube was passed down the 
trachea until slight resistance was met. The appropriate 
inoculation was made and incision sites were left open to 
prevent edema and air from being trapped in the soft 
tissues around the surgery site.
Treatment groups: Mice within each of the three 
inoculation groups (Phi, C, PBS) were divided 
into four treatment groups: 1) no pretreatment, 2) 
indomethacin pretreated, 3) NDGA pretreated ,and 4) 
hydroxyurea pretreated. Mice from each group were killed 
at 4 or 24 hours creating 24 groups including principle 
groups and control groups as follows:
4 hr Phi (no pretreatment) 24 hr Phi (no pretreatment)
4 hr Indo Phi 24 hr Indo Phi
4 hr NDGA Phi 24 hr NDGA Phi
4 hr Urea Phi 24 hr Urea Phi
4 hr C (no pretreatment) 24 hr C (no pretreatment)
4 hr Indo C 24 hr Indo C
4 hr NDGA C 24 hr NDGA C
4 hr Urea C 24 hr Urea C
4 hr PBS (no pretreatment) 24 hr PBS (no pretreatment)
4 hr Indo PBS 24 hr Indo PBS
4 hr NDGA PBS 24 hr NDGA PBS
4 hr Urea PBS 24 hr Urea PBS
Indomethacin and NDGA (Sigma Chemical Co., St.
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Louis, MO) were prepared fresh daily and inoculated as 
described by Kunkel, et al (124). Indomethacin and NDGA 
were initially prepared at 8 and 20 mg/ml, respectively, 
in 0.1 N NaOH and prior to injection were diluted in 
phosphate buffered saline (PBS). Indomethacin was diluted 
to 400 m icrograms/ml and NDGA was diluted to 2 mg/ml.
Mice received a subcutaneous injection of 250 micro liters 
of the appropriate inhibitor immediately prior to 
intrabronchial inoculation.
Neutropenic controls were obtained by pretreating 
mice with hydroxyurea (Sigma Chemical Co., St. Louis, Mo) 
for four consecutive days prior to intrabronchial 
inoculation. The procedure was modified from procedures 
used by Heflin and Brigham (94) to neutrophil deplete 
adult sheep and Slocombe, et al (98) to neutrophil 
deplete calves. Hydroxyurea was injected 
intraperitoneally at a dose of 0.1 mg/gram body weight.
A group of 8 mice were inoculated intrabronchially 
with Phi to serve as culture controls. Four of the mice 
were k i l l e d  at 4 hours and 4 were k i l l e d  at 24 hours. 
Lung, liver, spleen, and kidney from each mouse were 
aseptically collected and were cultured.
Evaluation: Mice were killed at 4 or 24 hours by 
cervical dislocation and routine necropsies were 
performed. Tissues were fixed by vascular perfusion with 
4% formaldehyde 1% gluteraldehyde (4F1G) followed by
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immersion in 4F1G. At the appropriate kill time the 
following samples were collected for analysis: whole 
blood for white cell counts; serum for enzyme analysis; 
pulmonary lavages for cell counts, ultrastructural 
examination and enzyme analysis; lungs for light 
microscopy and ultrastructural examination; and liver, 
spleen and kidney for light microscopy. Pulmonary lavages 
were obtained by infusing 1 ml of PBS into the lungs and 
recovering as much of the PBS as possible. A total of 4 
lavages were done on each mouse and the samples were 
pooled. Following the last lavage the lungs were airway 
perfused with 1 ml of 4F1G.
Total white blood cell counts and lavage cell counts 
were done by hand using a hemocytometer. Differential 
counts were performed on blood samples using Wright 
stained smears. Enzyme assays for beta-glucuronidase (B- 
gluc), myeloperoxidase (MPO) (154), and elastase (SAPNA) 
(155,156) were done spectrophotometrically on serum and 
lavage fliuds using kits from Sigma Chemical Co., St. 
Louis, MO. Procedures for analysis of the enzymes are 
given in Appendix I. If sample size permitted enzyme 
assays were done on samples from individual animals, 
however, samples were pooled within groups if sample sizes 
were too small to run the assays. Ce l l  counts and enzyme 
levels were evaluated statistically using a 2 X 3 X 4 
analysis of variance and Tukey's standardized range test.
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Tissues for light microscopy were embedded in 
paraffin, sectioned at 6 microns with a microtome, and 
stained with hematoxylin and eosin. Lung specimens for 
transmission electron microscopy were washed in 0.1 M 
sodium cacodylate containing 5% sucrose, post-fixed with 
1% osmium tetroxide in 0.1 M sodium cacodylate, and 
dehydrated through an ascending alcohol series (50-100%). 
This was followed by three washes in 100% propylene oxide 
followed by a series of propylene oxide and epon araldite 
in the ratios of 75%:25%, 50%:50%, 25%:75% propylene 
oxide to epon araldite. Samples were then infiltrated and 
embedded in epon araldite. Thin sections were cut on an 
ultramicrotome (Sorvall MT 5000, Ivan Sorvall, Inc., 
Norwalk, CT), were stained with uranyl acetate and lead 
citrate, and were examined on a transmission electron 
microscope (Zeiss EM 10, Carl Zeiss, Inc., New York, NY).
Lavage samples were centrifuged at 100 g to form a 
cell pellet, supernatants were removed and frozen for 
enzyme assays as described earlier, and cells were 
resuspended in 2% gluteraldehyde. After fixation cells 
were repelleted and fixative supernatant was discarded. 
The cells were washed with 0.1 M cacodylate buffer 3 
times and then half of the samples from each group were 
stained with 3,3'-diaminobenzidine (DAB) (Polysciences, 
Inc., Warrington, PA) as a marker of azurophil granules. 
The DAB staining technique was adapted from the procedure
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of Graham and Karnovsky (157) in which samples were 
incubated for one hour with DAB d i s s o l v e d  in 0.05 M Tris 
buffer, pH 7.6, plus 0.02% hydrogen peroxide at room 
temperature. After incubation cells were washed in Tris 
buffer 3 times, were post-fixed in 1% osmium tetroxide, 
and were then enrobed in 3% agarose. Agarose capsules 
containing the lavage cells were minced, dehydrated 
through alcohol and propylene oxide, and infiltrated and 
embedded in epon araldite. Thin sections were cut, 
stained, and examined with a transmission electron 
microscope as described previously for lung tissue.
RESULTS
Pasteurella inoculations
4 hour Phi (no pretreatment): Lesions were seen in 
8 of 9 mice in this group. Lesions were mild and were 
characterized by multifocal infiltration of the 
interstitiura and alveoli by neutrophils, proliferation of 
alveolar macrophages and congestion of interstitial blood 
vessels (Figure 1). Scattered hemorrhages were present 
in alveoli and in some sections there was slight edema 
accumulation in the interstitium. Neutrophil infiltration 
tended to be peribronchially distributed in some 
sections. There was often sludging of neutrophils in 
blood vessels.
4 hour Indo Phi: Lesions were more severe than 
those seen in the 4 hour Phi group. Increased severity
Fig. 1: 4 hr Phi (no pretreatment). Congestion of 
blood vessels, mild infiltration of interstitium and 
alveoli by neutrophils and macrophages.
was due to increased neutrophil infiltration in the 
interstitium and alveoli, increased numbers of alveolar 
macrophages, and edema accumulation in the interstitium 
and alveoli (Figure 2). In addition, there was scattered 
mild necrosis of alveolar septa characterized by 
accumulation of cell debris, pyknosis of cell nuclei, 
hemorrhage, and leakage of proteinaceous fluid. Lesions 
were multifocal to diffuse. In some sections there was 
slight fibrin exudation into alveoli.
4 hour NDGA Phi: Lesions in this group were less 
consistent than those in the two previous groups and 
ranged from essentially normal lungs to lungs with 
lesions similar to those in the 4 hour Indo Phi group. 
Interstitial edema, congestion, and neutrophil and 
macrophage infiltration characterized the worst lesions 
(Figure 3). The neutrophil infiltrate was frequently 
centered around bronchioles. Mild, scattered parenchymal 
necrosis was also present in some sections. In other 
sections the only lesions were scattered, mild, acute 
alveolar hemorrhages and congestion of interstitial bloo 
vessels.
4 hour Urea Phi: Lungs from most of the mice in 
this group had no lesions or only congestion of 
interstitial blood vessels and hemorrhage into alveoli. 
In a few sections there were foci with increased 
cellularity, however, the increase in cells was
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Fig. 2: 4 hr Indo Phi. Interstitial and alveolar edema, 
neutrophils, and macrophages.
Fig. 3: 4 hr NDGA Phi. Congestion, interstitial edema; 
neutrophil and macrophage infiltration.
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predominantly due to increased numbers of mononuclear 
cells including macrophages, lymphocytes, and plasma 
cells (Figure 4). In these areas there was also edema in 
the interstitium and alveoli. Blood vessels throughout 
the sections contained few or no neutrophils.
24 hour Phi (no pretreatment): Microscopic lesions 
were mild to moderate with multifocal to diffuse 
infiltration of alveoli by neutrophils and macrophages 
(Figure 5), edema accumulation in alveoli /and the 
interstitium, multifocal fibrin exudation and scattered 
alveolar hemorrhage. Neutrophil influx was more severe 
than that seen in any of the previous groups which 
received Phi and were killed at 4 hours post 
inoculation. Sequestration of neutrophils in blood 
v e s s e l s  was present in lungs of al l  mice in this group.
24 hour Indo Phi: Lesions were similar to those in 
the 24 hour Phi group in nature and severity.
Congestion, hemorrhage, fibrin exudation, and 
infiltration of alveoli by neutrophils and macrophages 
characterized the lesions (Figure 6). As in the previous 
group sequestration of neutrophils in interstitial blood 
vessels was present, even in sections with relatively 
mild lesions.
24 hour NDGA Phi: Lesions were generally milder 
than those seen in the 24 hour Phi and 24 hour Indo Phi 
groups. There was mild infiltration of alveoli by
69
Fig. 4: 4 hr Urea Phi. Mononuclear cell infiltration of 
interstitium and alveoli.
Fig. 5: 24 hr Phi (no pretreatment). Multifocal 
infiltration of alveoli by neutrophils.
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Fig. 6: 24 hr Indo Phi. Infiltration of alveoli by 
neutrophils and macrophages.
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neutrophils (Figure 7), congestion, alveolar hemorrhages, 
and slight fibrin exudation in most lungs. Lungs from 2 
of 8 mice had lesions similar in severity to the two 
previous groups. Occasionally there was infiltration of 
bronchiolar walls by neutrophils and accumulation of 
neutrophil clusters in terminal bronchioles.
In addition to pulmonary lesions, microscopic 
lesions were seen in sections of liver from 4 of 8 mice 
and in sections of spleen from 5 of 8 mice in this group. 
Three of the 8 mice had lesions in both liver and spleen. 
Hepatic lesions consisted of mild to moderate, 
multifocal, acute coagulation necrosis of hepatocytes. 
Hepatic lesions were centered around central veins or 
portal areas and were characterized by loss of cell 
outlines, pyknosis and karyorrhexis of hepatocyte nuclei, 
and no inflammatory reaction (Figures 8 & 9). Affected 
areas blend in with areas containing normal hepatocytes.
Mild to moderate acute lymphoid necrosis was present 
in spleens of 5 mice. The necrosis was evident 
predominantly in lymphoid follicles (Figure 10), but was 
also occasionally scattered with no definite location 
(Figure 11) and was characterized by pyknosis and 
karyorrhexis of cell nuclei and accumulation of cell 
debris. Gram's stains of sections of liver and spleen 
from affected mice revealed no microorganisms.
24 hour Urea Phi: V a s c u l a r  changes were the most
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Fig. 7: 24 hr NDGA Phi. Mi l d  infiltration of a l v e o l i  by 
neutrophils.
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Fig. 8: 24 hr NDGA Phi. Multifocal, angiocentric hepatic 
necrosis.
Fig. 9: 24 hr NDGA Phi. Hepatic necrosis with no 
inflammation.
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Fig. 10 & Fig. 11: 24 hr NDGA Phi. Lymphoid necrosis in 
spleen. Karyorrhexis and pyknosis of cell nuclei.
prominent lesions seen in most sections in this group. 
These changes included severe congestion of interstitial 
blood vessels, scattered hemorrhages, and edema 
accumulation (Figure 12). Increased numbers of alveolar 
macrophages were also present. In lungs from 2 of 7 mice 
numerous bacteria were seen in lung parenchyma and there 
was necrosis of parenchyma and infiltration of alveoli 
and interstitium by neutrophils and macrophages. In one 
of these two mice there was also moderate lymphoid 
necrosis in the spleen.
Carbon inoculations
4 hour carbon, 4 hour Indo carbon, 4 hour NDGA 
carbon, and 4 hour Urea carbon: No significant 
differences were seen among the four groups receiving 
carbon and killed at 4 hours post inoculation. Carbon 
phagocytosis was similar in the 4 groups. All groups had 
phagocytic cells engorged with carbon in alveoli as well 
as some free carbon in alveoli (Figures 13 & 14). 
Morphology of phagocytic cells was often obscured by the 
amount of carbon phagocytized, however, occasionally the 
cells could be identified as macrophages. Some 
bronchioles also contained carbon which was usually 
aligned along the apical borders of bronchiolar 
epithelium and was surrounded by mononuclear cells. Other 
changes present included mild alveolar hemorrhages, 
congestion of blood vessels and occasionally infiltration
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Fig. 12: 24 hr Urea Phi. Severe congestion of septal
blood vessels; alveolar edema.
Fig. 13: 4 hr C & Fig. 14: 4 hr NDGA C: Phagocytic cells 
engorged with carbonj free carbon adhered to alveolar 
lining.
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of alveoli by neutrophils. When neutrophil infiltration 
was present it was a focal, mild change.
24 hour carbon, 24 hour Indo carbon, 24 hour NDGA 
carbon, and 24 hour Urea carbon: There were no detectable 
differences among groups of mice receiving no 
pretreatraent, indomethacin, NDGA, or hydroxyurea and 
killed 24 hours after intrabronchial carbon inoculation. 
These groups contained significantly more phagocytic 
cells engorged with carbon (Figure 15) than equivalent 
groups killed at 4 hours post inoculation. In addition, 
more neutrophils and fibrin were present in alveoli 
(Figure 16) than in the 4 hour carbon groups. Cells 
containing phagocytized carbon in which nuclear 
morphology could be determined were always mononuclear 
cells. In addition to the phagocytic cells containing 
carbon and neutrophil infiltration there was multifocal 
congestion and occasional alveolar hemorrhage present. 
Controls
4 hour PBS, 4 hour Indo PBS, 4 hour NDGA PBS, and 4 
hour Urea PBS: Lungs of mice from these four groups had 
no microscopic lesions or slight interstitial edema and 
fibrin exudation into alveoli (Figures 17 & 18).
24 hour PBS, 24 hour Indo PBS, 24 hour NDGA PBS, and 
24 hour Urea PBS: As in the four hour controls there were 
no lesions or slight interstitial edema and alveolar 
fibrin exudation in the 24 hour controls (Figures 19 & 20).
79
Fig. 15: 24 hr Urea C. Increased phagocytic cells 
engorged with carbon.
Fig. 16: 24 hr Indo C. Phagocytic cells engorged with 
carbon; neutrophil infiltration and fibrin exudation in 
alveoli.
80
Fig. 17: 4 hr NDGA PBS. Slight interstitial edema. 
Fig. 18: 4 hr PBS (no pretreatment). No lesions.
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Fig. 19: 24 hr Urea PBS. No lesions.
Fig. 20: 24 hr PBS. Slight fibrin exudation into alveoli.
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Ultrastrucural changes are summarized as follows: 
Pasteurella inoculations
4 hour Phi (no pretreatment): Some alveoli 
contained neutrophils which had few granules and smooth 
cytoplasmic membranes with no filapodia (Figure 21). In 
other foci there was accumulation of proteinaceous fluid 
in the interstitium and in alveolar lumina. Endothelial 
cells of some blood vessels'were plump and contained 
clear variably sized cytoplasmic vacoules (Figure 22).
4 hour Indo Phi: In addition to occasional 
neutrophils in alveoli and the interstitium, increased 
numbers of alveolar macrophages were present. Alveolar 
macrophages frequently contained phagolysosomes and 
occasionally phagocytized bacteria were seen (Figure 23).
In other foci vascular endothelial cells were swollen 
and blood vessels contained fibrin thrombi.
4 hour NDGA Phi: Ultrastructural changes ranged 
from essentially normal lung tissue to infiltration of 
alveoli by macrophages and neutrophils, which sometimes 
contained phagocytized bacteria (Figure 24). In some foci 
alveolar macrophages were degenerate. Neutrophils 
obtained by pulmonary lavage contained numerous filapodia 
and adequate granules (Figure 25).
4 hour Urea Phi: Neutrophils were rarely observed 
in alveoli and within blood vessels. The interstitium was 
frequently widened due to congestion of blood vessels and
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Fig. 21: 4 hr Phi (no pretreatment). TEM of lung. 
Neutrophil with no filapodia and few granules.
Bar = 1 urn.
Fig. 22: 4 hr Phi (no pretreatment). TEM of lung.
Vascular endothelial cells with cytoplasmic vacuoles
(arrow). Bar = 1 um.
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Fig. 23: 4 hr Indo Phi. TEM of lung. Alveolar macrophage
with phagocytized bacteria (arrow). Bar = 1 um.
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Fig. 24: 4 hr NDGA Phi. TEM of lung. Phagocytic cell with 
bacterium (arrow). Bar = 1 um.
Fig. 25: 4 hr NDGA Phi. TEM of lavage cell. DAB stained 
neutrophil with numerous granules. Bar = 0.5 um.
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edema accumulation. Alveolar macrophages were frequently 
seen (Figure 26). Type II pneumocytes frequently 
contained abundant surfactant and had dark swollen 
mitochondria (Figure 27). Lavage samples contained 
primarily macrophages and many bacteria.
24 hour Phi: Neutrophil influx into alveolar lumina 
was a common finding in lungs of this group. Occasionally 
disruption of septal membranes was present in foci 
containing neutrophils (Figure 28). Lavage samples 
contained neutrophils with phagocytized bacteria and 
degenerate neutrophils with vacuolated cytoplasm and few 
granules.
24 hour Indo Phi: In some foci a l v e o l i  contained 
neutrophils even though no changes were apparent in the 
interstitium and blood vessels. In other areas there was 
congestion of blood vessels and widening of the 
interstitium due to increased cellularity, primarily 
mononuclear cells. Neutrophils in alveoli frequently 
contained phagocytized bacteria (Figure 29). Lavage 
samples contained neutrophils with few primary granules 
(Figure 30).
24 hour NDGA Phi: Alveoli were infiltrated by many 
neutrophils and macrophages which contained phagocytized 
bacteria. Neutrophils contained phagocytized bacteria and 
few granules (Figure 31). Other foci contained hemorrhage 
in addition to the cellular infiltrate. Neutrophils from
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Fig. 26: 4 hr Urea Phi. TEM of lung. Alveolar macrophage; 
slight interstitial widening. Bar = 2 um.
Fig. 27: 4 hr Urea Phi. TEM of lung. Type II pneumonocyte
with abundant surfactant. Bar = 0.5 um.
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Fig. 28: 24 hr Phi (no pretreatment). TEM of lung. 
Neutrophil infiltration of alveoli; disruption of septal 
membranes. Bar = 2 um.
Fig. 29: 24 hr Indo Phi. TEM of lung. Neutrophil with
phagocytized bacterium (arrow). Bar = 0.5 um.
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Fig. 30: 24 hr Indo Phi. TEM of lavage cell. DAB stained 
cell with few primary granules. Bar = 0.5 um.
Fig. 31: 24 hr NDGA Phi. TEM of lung. Neutrophils with
phagocytized bacteria (arrow) and few granules. Bar = 1 um.
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lavage also contained phagocytized bacteria and few 
granules (Figure 32).
24 hour Urea Phi: Neutrophil infiltration was 
markedly decreased in this group, although neutrophils 
were occasionally seen. Congestion of blood vessels in 
alveolar septa was a common finding (Figure 33). 
Neutrophils were present in lavage samples and those seen 
contained many bacteria. Some neutrophils were degenerate 
with loss of cytoplasmic extensions, vacuolation of 
cytoplasm and loss of granule contents (Figure 34).
Carbon inoculations
4 hour carbon, 4 hour Indo carbon, 4 hour NDGA 
carbon, and 4 hour Urea carbon: No differences were seen 
among the four groups receiving carbon inoculations. In 
all groups carbon was phagocytized by macrophages (Figures 
35 & 36). Neutrophils were usually not seen, but when 
present had not phagocytized carbon. Other lesions were 
usually not seen other than occasional hemorrhage into 
alveoli. Lavage samples contained macrophages, some 
containing carbon, and neutrophils.
24 hour carbon, 24 hour Indo' carbon, 24 hour NDGA 
carbon, and 24 hour Urea carbon: At 24 hours post 
inoculation neutrophil infiltration had occurred in some 
lungs (Figures 37 & 38), however, phagocytosis of carbon 
was still accomplished by macrophages (Figure 39). In 
addition, in some foci carbon was present within the
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Fig. 32: 24 hr NDGA Phi. TEM of lavage cell. DAB stained
neutrophil with phagocytized bacteria (arrow) and few
granules. Bar = 0.5 um.
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Fig. 33: 24 hr Urea Phi. TEM of lung. Congestion of 
septal blood vessels. Bar = 2 um.
Fig. 34: 24 hr Urea Phi. TEM of lavage cells. DAB stained
neutrophils; degenerate neutrophil with cytoplasmic
vacuolation and loss of granules (arrow). Bar = 0.5 um.
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Fig. 35: 4 hr Indo C & Fig. 36: 4 hr C (no pretreatment). 
TEM of lung. Macrophages with phagocytized carbon.
Fig. 35: Bar = 1 um; Fig- 36: Bar = 0.5 um.
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Fig. 37: 24 hr C (no pretreatment). TEM of lung. 
Neutrophil infiltration of alveoli. Bar = 2 um.
Fig. 38: 24 hr NDGA C. TEM of lung. Neutrophil with
numerous granules in alveolar lumen; free C. Bar = 0.5 um.
95
Fig. 39: 24 hr NDGA C. TEM of lung. Phagocytosis of
carbon by macrophage. Bar = 0.5 um.
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interstitium (Figure 40). No appreciable differences in 
carbon phagocytosis were detected among the four groups. 
Saline inoculations
4 hour PBS, 4 hour Indo PBS, 4 hour NDGA PBS, 4 hour 
Urea PBS: Blood vesels in alveolar septa were sometimes 
congested (Figure 41). Otherwise, no lesions were 
observed in lung tissue of controls from the four groups. 
Alveolar macrophages (Figure 42) were occasionally seen. 
Lavage samples contained hemorrhage, macrophages, and 
neutrophils.
24 hour PBS, 24 hour Indo PBS, 24 hour NDGA PBS, 24 
hour Urea PBS: Lungs from these groups were similar to 
those from the 4 hour controls with congestion of blood 
vessels being the predominant change (Figure 43). 
Alveolar macrophages and hemorrhage were present in 
alveoli (Figure 44). Lavage samples contained hemorrhage, 
macrophages and a few neutrophils.
Cell Counts and Enzyme Results
No significant differences (p < 0.05) were present 
among the 24 groups in white blood cell count, neutrophil 
count, lavage cell count, and enzyme activities of MPO, 
MPO/lavage cell, elastase (SAPNA), elastase/lavage cell, 
serum MPO, or serum B-gluc in saline, carbon, or Phi 
inoculated mice at 4 or 24 hours (Tables I-VI). At 4 hr 
there was a significant increase in lavage B-gluc in Phi 
inoculated non-pretreated mice when compared to PBS
Fig. 40: 24 hr C (no pretreatment). TEM of lung. Carbon 
within interstitium. Bar = 0.5 um.
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Fig. 41: 4 hr PBS (no pretreatment). TEM of lung. 
Congestion of septal blood vessels. Bar = 2 um.
Fig. 42: 4 hr Urea PBS. TEM of lung. Alveolar macrophage;
thin septa. Bar = 2 um.
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Fig. 43: 24 hr Indo PBS. TEM of lung. Thin alveolar 
septum. Bar = 0.5 um.
Fig. 44: 24 hr Urea PBS. TEM of lung. Alveolar
macrophage; hemorrhage in alveolus. Bar = 2 um.
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inoculated non-pretreated mice (Table I). At 24 hours 
Indo pretreated Phi inoculated and Urea pretreated Phi 
inoculated mice had significantly higher lavage B-gluc 
levels than non-pretreated Phi inoculated, NDGA 
pretreated Phi inoculated and non-pretreated PBS 
inoculated mice (Table II). Urea pretreated carbon 
inoculated mice had significantly lower lavage B-gluc 
levels than NDGA pretreated carbon inoculated mice at 24 
hours (Table III). Significant differences were not 
present in lavage B-gluc levels in 4 hr carbon inoculated 
groups, 4 hr PBS inoculated groups, or 24 hr PBS 
inoculated groups (Tables III,V,VI). Lavage B-gluc/lavage 
cell was significantly different only in the 24 hr Phi 
group in which Urea pretreated mice had a higher enzyme 
level per cell than non-pretreated, Indo pretreated, NDGA 
pretreated Phi inoculated ,and non-pretreated PBS 
inoculated mice (Table II).
Tables for the results given above were generated 
from a 2 X 3 X 4 analysis of variance and Tukey's 
studentized range test, and represent the findings from 
the three way interaction of inoculum, treatment and 
time. Other significant differences were seen due to 
single factors or two way interactions and are summarized 
in the following chart.
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I=Inoculation (Phi, Carbon, PBS) 
Tx=Treatment (None, Indo, NDGA, Urea) 
T=Time (4 hr, 24 hr)
Variable I Tx T I*Tx I*T Tx*T I*Tx*T
WBC + + + — + — —
Segs - + - - - - -
Lav cell count - - + - + - -
Ser MPO - - + - — + -
Ser B-gluc - - + - + + -
Lav SAPNA — — + - — - -
Lav SAPNA/cell - — + - + - -
Lav MPO - — + — — - -
Lav MPO/cell - - + - - - -
Lav B-gluc + - + - + - +
Lav B-gluc/cell + + + + + — +
+ = Significant differences present (p<.05)
- = No significant differences present (p>.05)
Inoculation effects were seen on WBC counts, lavage 
B-gluc and lavage B-gluc/cell levels (Table VII). Phi 
caused a decrease in WBC count when compared to C or PBS 
inoculated mice. Lavage B-gluc activity was divided into 
3 significantly different groups: PBS < Phi < C. Lavage 
B-gluc/cell was higher in Phi inoculated mice than in C 
or PBS inoculated mice.
Treatment effects were seen in WBC count,
f
neutrophil count, and lavage B-gluc levels (Table VIII). 
Non-pretreated and Urea pretreated mice had lower WBC 
counts than Indo or NDGA pretreated mice. Hydroxyurea 
caused a significant decrease in neutrophil count when 
compared to non-pretreated, Indo pretreated, or NDGA 
pretreated mice. Lavage B-gluc/cell was higher in Urea
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pretreated vs Indo, NDGA, or non-pretreated mice.
The effect of time was the single factor which 
caused the most differences (Table IX). Lavage cell 
count, serum MPO, serum B-gluc, and lavage B-gluc were 
al l  higher at 4 hours than 24 hours. WBC count, lavage 
elastase, lavage elastase/cel1, lavage MPO, lavage 
MPO/cell, and lavage B-gluc/cell were all lower at 4 
hours than 24 hours.
The only effect of inoculation X treatment was in 
lavage B-gluc/cell levels of Phi inoculated mice 
(Tables X, XI, XII). Urea pretreated Phi inoculated mice 
had higher lavage B-gluc/cell activity than NDGA 
pretreated Phi inoculated or non-pretreated PBS 
inoculated mice (Table X).
Inoculation X time had effects on several variables 
(Tables XIII & XIV). At 4 hours, C inoculated mice had 
higher WBC counts than PBS inoculated mice. Serum B-gluc 
levels in Phi inoculated mice were lower than levels in C 
inoculated, but not PBS inoculated mice. At 4 hours 
lavage B-gluc was divided into 3 significantly different 
groups: C > Phi > PBS.
At 24 hours (Table XIV) 3 significantly different 
groups were present with respect to WBC count: PBS > C > 
Phi. Lavage cell count was lower in Phi inoculated vs PBS 
or C inoculated mice at 24 hours. Lavage elastase/cel 1 
was higher in Phi inoculated vs C or PBS inoculated mice
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at 24 hours. Both Phi and C inoculated mice had higher 
lavage B-gluc levels than PBS inoculated mice at 24 
hours, however, Phi inoculated mice had higher lavage B- 
gluc/cell activity than C or PBS inoculated mice.
The only differences seen in treatment X time 
interactions were in serum MPO activity and serum B-gluc 
activity at 4 hours (Tables XV & XVI). Indo pretreated 
mice had lower serum MPO levels than NDGA pretreated mice 
and Urea pretreated mice had lower serum B-gluc levels 
than NDGA pretreated mice.
Bacterial Cultures
Culture results from the 8 mice inoculated with Phi 
with no pretreatraent are given in the following chart.
Mouse Kill Time Lung Liver Spleen Kidney
A 4 hr + + + +
B 4 hr + + + +
C 4 hr ++ + + +
D 4 hr + + + +
E 24 hr ++ ++ ++ NG
F 24 hr + +++ NG NG
G 24 hr ++ Gr Gr Gr
H 24 hr died ++ + + +
early
+ = Phi recovered
++ = Mixed colony, Phi recovered
+++ = Phi on enrichment
NG = No Growth
Gr = Growth (no Phi)
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DISCUSSION
Morphologic lesions in 4 hour and 24 hour Phi 
inoculated mice can be categorized by severity as 
follows: Urea < NDGA < non-pretreated < Indo. At 24 hours 
the differences between non-pretreated and Indo treated 
mice were minimal. Even though NDGA pretreated mice had 
less severe morphologic lesions than Indo or non- 
pretreated mice the differences were less dramatic than 
expected. NDGA pretreated mice had more inconsistency 
from mouse to mouse than the other treatment groups.
Reasons for the inconsistency and less dramatic overall 
effect of NDGA than expected are uncertain. Possible 
explanations are that the drug does not produce the 
effect ill vivo that it does jiii vitro on neutrophils, 
dosage of the drug may have been inadequate, and effects 
of the drug may have been overcome by other factors.
In vivo effects of NDGA have been reported (124), 
however, those studies were done with a different type of 
lesion. Bray (137) states that NDGA is a good 
lipoxygenase inhibitor but has little jin vivo anti­
inflammatory effect. In jin vitro studies (133) LTB^ 
production by alveolar macrophages could be dropped to 0 
with NDGA, however, this effect could not be repeated 
after zymosan phagocytosis. It is reasonable to assume 
that even though effects of the drug may have been 
achieved, the interaction of other factors (phagocytosis,
other inflammatory modulators) may have offset drug 
effect.
The drug dosages used in the present study were 
those used in previous studies (124) and may not 
represent the proper dose needed to achieve optimum 
results in the mouse model of bovine pneumonic 
pasteurellosis.
Lesions seen in liver and spleen of some of the NDGA 
pretreated Phi inoculated mice at 24 hours but not at 4 
hours were possibly the result of unknown interactions of 
bacterial endotoxin and other factors or septicemia. NDGA 
may have altered the host response enough to allow the 
bacteria to have different effects than in the other Phi 
inoculated groups. Lesions are not likely to be due to 
drug toxicity because similar lesions were not seen in 24 
hour NDGA pretreated C inoculated or PBS inoculated 
groups or in any of the 4 hour NDGA pretreated groups.
Lesions in Indo pretreated mice were as severe or 
more severe than in non-pretreated mice. This finding is 
in agreement with studies which show that prostaglandins 
have antagonistic effects and, therefore, may have 
counteractive effects on inflammatory lesions (123-125). 
The increased severity of lesions in some Indo pretreated 
mice can be explained by the fact that inhibition of the 
cyclooxygenase pathway of arachidonic acid shifts more 
substrate to the lipoxygenase pathway (116) and, therefor
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more LTB^ may be formed.
Only some of the expected differences in cell counts 
and enzyme levels were seen while others were not. Even 
though statistically significant differences were not 
always present, trends which fit the expected patterns 
were often occurred. Graphic representation of some of 
the more important differences and trends are displayed 
in Appendix III.
WBC counts were lower in Phi inoculated mice as is 
expected with infection by a bacterial organism. The 
decrease in WBC count in Urea pretreated mice was due 
primarily to neutropenia, and when only the treatment 
effect is analyzed neutrophils were significantly lower 
ih Urea pretreated groups (Table VIII). This decrease was 
not significant when comparing individual groups in the 3 
way interaction of the ANOVA, however, Urea pretreated 
groups were clustered at the lower end of the range of 
values (Graph I). The reason for significant differences 
in WBC and neutrophil counts when examining single 
factors such as inoculation and treatment, and no 
significant differences among the 24 experimental groups 
is at least partially due to the way variance is computed 
in the statistical analysis. If observation number is 
large, as when comparing all NDGA pretreated mice to all 
Indo pretreated mice, then variance will be small making 
it easier to detect differences between the groups. On
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the other hand, if observation number is small, as when 
comparing 4 hr NDGA pretreated Phi inoculated mice to 4 
hr Indo pretreated Phi inoculated mice, then variance is 
large making it harder to detect differences between the 
groups.
Significant differences were seen between 4 and 24 
hours in all variables except neutrophil count. This 
response was responsible for some of the interaction 
differences, but, by itself was of little value in 
evaluating this data.
The most interesting trend in lavage cell counts was 
in Phi inoculated mice in which, regardless of 
pretreatment, at 24 hours cell counts were decreased when 
compared to 4 hour cell counts (Graph II). The same 
effect was not seen in C or PBS inoculated mice 
(Graph III). This effect might be explained by the 
potential killing action of the bacteria on leukocytes 
and may also help explain the higher lavage B-gluc/cell 
activity in Phi groups vs C or PBS groups (Table VII). 
However, the cause of the significant difference in 
lavage B-gluc/cell was due to the 24 hour Urea pretreated 
Phi inoculated group having higher activity per cell than 
all other groups (Graph IV), while other Phi inoculated 
groups usually did not have higher lavage B-gluc/cell 
than C or PBS inoculated groups.
Lavage elastase/cel 1 was not significantly different
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among the groups, however, NDGA pretreated Phi inoculated 
mice at 4 and 24 hours and NDGA pretreated C inoculated 
mice at 4 hours had lower elastase/cel1 activity possibly 
due to inhibition of degranulation by the drug (Graph V).
The same type of trend was seen in lavage MPO/cell levels 
for NDGA pretreated Phi inoculated mice at 4 hours, but 
not at 24 hours post inoculation, while NDGA pretreated C 
inoculated mice had lower lavage MPO/cell levels at 24 
hours, but not at 4 hours (Graph VI).
Closer examination of only the Phi inoculated groups 
shows that there was a decrease, although not significantly 
different, in lavage B-gluc/cell, elastase/cel1, and 
MPO/cell levels with NDGA pretreatraent at 4 hours (Graphs 
VII, VIII, IX). A similar effect was seen at 24 hours 
only in lavage elastase/cell, as mentioned previously 
(Graph V). Loss of drug effect by 24 hours could explain 
the lack of the trend at 24 hours, since the mice were 
only treated with one injection of NDGA.
From a morphologic standpoint the overall assessment 
of the effects of arachidonic acid inhibitors on 
pulmonary lesions in mice is that NDGA pretreated Phi 
inoculated mice had less severe lesions than non­
pretreated or Indo pretreated Phi inoculated mice, even 
though the changes were not dramatic. Lesions were the 
least severe in Urea pretreated mice as expected. With 
respect to lavage enzyme levels NDGA pretreated mice had
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lower B-gluc/cell, MPO/cell and elastase/cel 1 enzyme 
activity in Phi inoculated mice at 4 hours when compared 
to other pretreatraents, but, these changes were not 
consistent at 24 hours ,nor were they statistically 
significant. This indicated that inflammatory mediators 
other than those being modified may have overcome any 
drug induced effect or that different dosages or 
different dosage intervals may be needed to achieve the 
desired in vivo effect.
*CHAPTER V 
SUMMARY AND CONCLUSIONS
Research in bovine respiratory disease is costly and 
time consuming. Attempts to produce laboratory animal 
models of bovine pneumonic pasteurellosis have had 
limited success. Disease has been produced when 
additional substances such as hemoglobin (80), gastric 
mucin (72,73), or high weight dextran sulfates (71) are 
given with the inoculum to enhance virulence of the 
organism. Little or no disease was produced when 
conventionally raised and germfree mice were inoculated 
by oral, aerogenic, or intraperitoneal routes with 
Pasteurella haemolytica serotype 1 (Phi) (80).
Chapter II of this dissertation describes a method
of producing pulmonary lesions in mice by intrabronchial
inoculation with Phi while permitting survival of the
mice for at least 24 hours. Five different exponential
doses, 5 X 10^ to 5 X 10® colony forming units (CFU), of
Phi were inoculated into different groups of mice and
lesions were evaluated at 24 hours. Lesions were produced
in mice of all dosage groups, however, lesions were not
7 8consistent except at 5 X 10 and 5 X 10 dosage levels.
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Lesions included neutrophil infiltration of alveoli and 
interstitium, fibrin thrombi formation, parenchymal 
necrosis, and fibrin exudation. The higher dose caused 
the most severe lesions but also caused more mice to die 
before 24 hours post inoculation. Therefore, 5 X 10^ CFU 
of Phi inoculated intrabronchially is a suitable dose to 
produce pulmonary lesions in a mouse model of bovine 
pneumonic pasteurellosis.
Neutrophils are known to be a contributing factor in 
lesion development in a variety of conditions (92-96). 
Depletion of neutrophils has been shown to decrease 
pulmonary lesion development in experimental bovine 
pneumonic pasteurellosis (97,98). Chapter III describes 
an experiment in which mice were inoculated with 5 X 10^ 
CFU of Phi by the technique used in Chapter II and were 
killed at sequential timepoints (2,4,8,12,&24 hours) to 
determine the timepoint at which neutrophils became a 
factor in pulmonary lesion development in this model. 
Lesions were produced at all 5 timepoints and had the 
same components as described earlier. Four hours post 
inoculation was the minimal time required to produce 
consistent pulmonary lesions with neutrophil involvement.
Neutrophils are capable of producing leukotriene 
(LTB^), a product of the lipoxygenase pathway of 
arachidonic acid metabolism. LTB^ is an inducer of 
neutrophil degranulation (92,129,138-140) and a potent
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chemotactic agent for neutrophils (92,117,129,130,135- 
137). This property is one of the mechanisms by which 
neutrophils are capable of inducing host tissue damage in 
inflammatory conditions. When neutrophils are recruited 
to the lung by antigenic stimuli they release lysosomal 
enzymes, causing tissue damage and generating LTB^ which 
causes more neutrophil chemotaxis and degranulation.
Prostaglandins, products of the cyclooxygenase 
pathway of arachidonic acid metabolism, have antagonistic 
effects on the inflammatory process (123-125). Inhibition 
of the lipoxygenase pathway should decrease pulmonary 
lesions induced by Phi inoculation while inhibition of 
the cyclooxygenase pathway should have little or no 
effect.
In Chapter IV mice were inoculated with one of three 
inocula: Phi, Carbon (C), or saline (PBS);, Within each 
inoculation group 4 pretreatraent groups were assigned: 
none; Indomethacin (Indo), a cyclooxygenase inhibitor; 
NDGA, a lipoxygenase inhibitor; or hydroxyurea (Urea), 
which depletes neutrophils. Mice were killed at 4 or 24 
hours post inoculation and lungs were examined '
microscopically and ultrastructurally. In addition, blood 
and pulmonary lavage samples were analyzed by cell counts 
and enzyme levels (B-glucuronidase, elastase, 
myeloperoxidase) to determine treatment effects.
Microscopically and ultrastructurally pulmonary
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lesions in Phi inoculated mice were least severe in Urea 
pretreated mice, followed by NDGA pretreated mice, and 
then non-pretreated and Indo pretreated mice. This was 
the expected effect, however, the differences were not as 
dramatic as expected. Use of inadequate drug dose may 
have contreibuted to less than desired effects, even 
though the expected trend was seen. Also, the action of 
other inflammatory mediators, such as complement 
activation, may have offset any LTB^ reduction due to 
NDGA pretreatment.
Lavage MPO/cell, lavage elastase/cel1, and lavage B- 
gluc/cell levels were lower in NDGA pretreated Phi 
inoculated mice than in non-pretreated, Indo pretreated 
or Urea pretreated Phi inoculated mice at 4 hours. The 
same changes were not seen at 24 hours with Phi 
inoculation or at either timepoint with C or PBS 
inoculations with any consistency. These changes were not 
statistically significant, but, do exhibit a trend which 
indicates that NDGA may have exerted the desired effect 
at a lower level than expected. Alteration of drug dose 
or dosage interval might increase the effect and produce 
more dramatic morphologic changes as well as lower 
enzymatic levels.
No differences could be detected in carbon 
phagocytosis among the 4 pretreatment groups at 4 or 24 
hours and other parameters were not consistently altered.
The results of this study indicate that further 
studies with NDGA treatment and Phi inoculation could 
result in more dramatic modulation of pulmonary lesions. 
Drug dosage and dosage interval are two areas in which 
alterations might produce different effects.
In summary, a mouse model of bovine pneumonic 
pasteurellosis was produced. The dose of Phi inoculum 
required to produce pulmonary lesions and the temporal 
evolution of those lesions were determined. Finally, 
modulation of pulmonary lesions in the mouse model was 
achieved, however, the modulation was less than expected.
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BETA-GLUCURONIDASE ASSAY
1] Use two tubes for each sample to be assayed. Label one 
tube BLANK, label the other TEST.
2] Label a third tube REAGENT BLANK. One reagent blank is 
used for each series of tests.
3] Add reagents in mis as follows and mix by swirling:
Component Reagent Sample[blank] Test
acetate buffer soln 0.3 0.3 0.3
phenolphthalein 
glucuronic acid
0.1 --- 0.1
d h 2o 0.1 0.1 ---
Serum or Lavage --- 0.1 0.1
4] Incubate in 56 degree C water bath for 60 minutes.
5] Add 2.5 ml of AMP buffer to each tube and mix by 
inversion.
6] Read absorbance [A] of reagent blank and of the sample 
blanks and tests at 550 nm vs H20 as reference [0],
7] Determine corrected A of test:
Corrected A = A tegt - [Asamp^e biank + A reagent blank^
8] Using the corrected A, determine phenolphthalein 
concentration [ug/ml] from the calibration curve.
9] Sample beta-glucuronidase activity [Modified Sigma 
Units] = phenolphthalein concentration [ug/ml] X 30.
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Beta-glucuronidase calibration curve
1] Prepare diluents for phenolphthalein standards as
follows: 3.6 ml acetate buffer, 2.4 ml 1^0, 30.0 ml
AMP buffer.
2] Prepare a diluted phenolphthalein solution [40 ug/ml] 
by combining: 0.2 ml phenolphthalein standard solution
and 4.8 ml of diluent from step 1.
3] Prepare calibration solutions as follows:
Tube # ml of 2 Sample diluent Absorb [Phenolphthal ]
1 0.3 5.7 2.0
2 0.6 5.4 4.0
3 0.9 5.1 6.0
4 1.2 4.8 8.0
4] Read A of tubes 1-4 at 550 nm using 1^0 as reference.
5] Plot a calibration curve of A vs [phenolphthalein].
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MYELOPEROXIDASE ASSAY
1] Prepare standard dilutions [dilute with phosphate 
buffer]. Use at least 3 dilutions between 1:5000 and 
1:80000.
2] Dilute H 20 2 1/60 [ 0.1 ml 3% H 20 2 + 5.9 ml dis t i l l e d
h 20]
3] Pipette 0.25 ml of phosphate buffer into each tube.
4] Add 0.3 ml of Hank's BSA to each tube.
5] Add 0.1 ml of sample.
6] Add 0.05 ml of diluted H 202
7] Add 0.05 ml of o-dianisidine.
8] Incubate for 15 minutes at room temperature.
9] Stop the reaction by addition of 0.05 ml NaNg
10] Read the optical density at 460 nm against the 
reagent blank.
11] MP0 activity is determined by comparing 0. D. reading 
of the sample to the standard curve to give units/ml 
of activity.
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ELASTASE ASSAY
Elastase activity is determined using a synthetic 
substrate, SAPNA [N-succinyl-L-alanyl-L-alanyl-L-alanine 
p-nitroanalide],
SAPNA is prepared as a 125 mM stock solution in N- 
methypyrolidone.
Porcine pancreatic elastase is used as the enzyme 
standard.
1] Dilute elastase samples in 0,2 M Tris HCL buffer, pH 
8.0. Add 2.5 ml of diluted sample to a 1 cm cuvette.
2] Equilibrate to 25 degrees C in a water bath.
3] Add 20 ul stock solution of SAPNA substrate.
4] Stop the reaction at 18 hours by addition of 100 ul of 
glacial acetic acid.
5] Read opitical density at 410 nra as measured against a 
substrate control with no added enzyme.
6] Optical density reading is compared to the standard 
curve to give activity [ug/ml] directly from the 
curve.
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TABLE I: 4 hr Phi
Pretreatraent
Variable!means] None Indo NDGA Urea PBS
WBC !/ul] 3011 2804 3693 1053 2210
Segs [/ul] , 971 1457 1660 111 705
Lav Cell [/ul] 11833 9583 23450 11427 13270
Ser m p o  @ 0.745 0.204 0.805 0.603 0.213
Ser B-gluc @ 0 0.3 5.6 0 31.2
Lav SAPNA @ 4.37 4.33 4.28 4.33 5.86
Lav SAPNA/cell 0.0004 0.0005 0.0002 0.0016 0.0005
Lav MPO @ 0.0068 0.007 0.0101 0.0068 0.0036
Lav MPO/cell # 0.0056 0.0097 0.0037 0.0199 0.0025
Lav B-gluc @ 10.13 8.03 7.73 6.35 .48*
Lav B-gluc/cell 0.001 0.001 0.0005 0.0018 0.00003
@: MPO=units/ml ; B-gluc=units/ml ; SAPNA=ug/ml 
#: Values are Lav MPO/cell X 10000
* Lav B-gluc significantly higher in non-pretreated Phi 
inoculated than in non-pretreated PBS controls [p<0.05] 
Other values not significantly different [NS]
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Table II: 24 hr Phi
Pretreatment
Variable[means] None Indo NDGA Urea PBS
WBC[/ul] 2258 2650 929 850 6770
Segs[/ul] 1177 1036 364 198 1014
Lav cell[/ul] 1521 2788 1478 1733 7550
Ser MPO @ 0.294 0.344 0.15 0.48 0.311
Ser B-gluc @ 0 0 6 57 6
Lav SAPNA @ 4.72 6.15 4.28 5.42 6.18
Lav SAPNA/cell 0.013 0.0051 0.0032 0.0068 0.0005
Lav MPO @ 0.0108 0.0078 0.008 0.008 0.013
Lav MPO/cell # 0.0852 0.055 0.1163 0.2531 0.0151
Lav B-gluc @ 0.4 10.25 0.49 9.55 0.24*
Lav B-gluc/cell 0.002 0.0076 0.001 0.0216 0.00005**
MPO=units/ml ; B-gluc=units/ml ; SAPNA=ug/ml
#: Values are Lav MPO/cell X 10000
* Non-pretreated and NDGA pretreated Phi and Non-
pretreated PBS are significantly less than Indo and
Urea pretreated Phi groups [p<0.05]
** Urea pretreated Phi is higher than all other groups 
[p<0.05 ]
Table III: 4 hr Carbon
Pretreatment
Variable[means] None Indo NDGA Urea
WBC[/ul] 3754 4450 5760 2920
Segs[/ul] 1310 1525 1800 543
Lav Cell[/ul] 12625 7075 11200 7880
Ser MPO @ 0.501 0.23 0.65 0.261
Ser B-gluc @ 22.9 43.0 92.4 32.6
Lav SAPNA @ 4.89 4.37 6.9 3.25
Lav SAPNA/cell 0.0005 0.0007 0.0002 0.0004
Lav MPO @ 0.0115 0.0051 0.0042 0.0057
Lav MPO/cell 0.0106 0.0101 0.0079 0.0065
Lav B-gluc @ 12.04 11.95 6.56 13.5
Lav B-gluc/cell 0.0011 0.0024 0.001 0.002
MP0=units/ml ; B-gluc=units/ml ; SAPNA=ug/ml
#: Values are Lav/cell X 10000
No significant differences present
Table IV : 24 hr Carbon
Pretreatment
Variable[means] None Indo NDGA Urea
WBC[/ul] 4200 4121 4594 2360
Segs[/ul] 1785 831 1681 290
Lav cell[/ul] 7513 8414 11445 10029
Ser MPO @ 0.27 0.27 0.297 0.51
Ser B-gluc @ 0 0 3.5 0
Lav SAPNA @ 6.7 9.28 5.7 5.85
Lav SAPNA/cell 0.0014 0.0018 0.0019 0.0018
Lav MPO @ 0.0089 0.0128 0.0115 0.0223
Lav MPO/cell # 0.046 0.0314 0.0271 0.0735
Lav B-gluc @ 4.38 4.67 11.88 2.65*
Lav B-gluc/cell 0.0017 0.0021 0.004 0.0007
@: MPO=units/ml ; B-gluc=units/ml ; SAPNA=ug/ml 
#: Values are Lav MPO/cell X 10000
* Urea pretreated less than NDGA pretreated [p<0.05]
Table V: 4 hr PBS
Pretreatment
Variable[means] None Indo NDGA Urea
WBC[/u l ] 2210 1375 3288 1580
Segs[/ul] 705 421 1170 396
Lav cell[/ul] 13270 6613 6438 5960
Ser MPO @ 0.213 0.445 0.572 0.359
Ser B-gluc @ 31.2 6.6 57.6 0
Lav SAPNA § 5.86 5.97 4.93 5.86
Lav SAPNA/cell 0.0005 0.0012 0.0014 0.0016
Lav MPO @ 0.0036 0.0083 0.0081 0.0051
Lav MPO/cell # 0.0025 0.0142 0.0248 0.0085
Lav B-gluc @ 0.48 0.9 0.3 0
Lav B-gluc/cell 0 0.0001 0.0002 0
MPO=units/ml ; B-gluc=units/ml ; SAPNA=ug/ml
#: Values are Lav MPO/cell X 10000
No significant differences present
Table VI: 24 hr PBS
Pretreatment
Variable[means] None Indo NDGA Urea
WBC[/ul ] 6770 5757 7850 5983
Segs[/ul] 1014 1142 2255 403
Lav cell[/ul] 7550 4143 6250 4942
Ser MPO @ 0.311 0.27 0.379 0.248
Ser B-gluc @ 6.0 22.9 18.0 19.1
Lav SAPNA @ 6.18 7.15 8.35 6.43
Lav SAPNA/cell 0.0012 0.0027 0.0053 0.0021
Lav MPO @ 0.013 0.0097 0.0161 0.0171
Lav MPO/cell # 0.0151 0.0527 0.0657 0.0366
Lav B-gluc @ 0.24 0.21 0.08 0
Lav B-gluc/cell 0 0 0 0
@: MPO=units/ml ; B-gluc=units/ml ; SAPNA=ug/ml 
#: Values are Lav MPO/cell X 10000 
No significant differences present
Table VII: Inoculation
Inoculation
Variable[means] Phi C PBS
WBC[/ul] 2133 4047 4476*
Segs[/ul] 833 1277 909
Lav cells[/ul] 6694 9947 6744
Ser MPO @ .5304 .3675 .3235
Ser B-gluc @ 19.39 26.55 3.83
Lav SAPNA @ 4.71 5.94 6.23
Lav SAPNA/cell .0046 .0019 .0017
Lav MPO @ .0080 .0107 .0102
Lav MPO/cell # .0074 .0025 .0028
Lav B-gluc @ 6.10 8.83 .26**
Lav B-gluc/cell .0048 .0019 .0001***
@: MPO=units/ml : B-gluc=units/ml ; SAPNA=
#: Values are Lav MPO/cell X 10000
* Phi WBC less than C or PBS WBC [p<.05]
** PBS < Phi < C [p<0.05] 
*** Phi > C or PBS [.<0.05]
Table VIII; Treatment
Treatment
Variable[means]
WBC[/ul]
Segs[/ul]
Lav Cells [/ul] 
Ser MPO @
Ser B-gluc @
Lav SAPNA @
Lav SAPNA/cell 
Lav MPO @
Lav MPO/cell # 
Lav B-gluc @
Lav B-gluc/cell
None Indo
3650 3793
1198 1125
9302 6304
0.4257 0.2774
14.03 20.19
5.33 6.53
0.0032 0.0022
0.0098 0.0088
0.0277 0.0322
6.077 5.9
0.001 0.0024
NDGA Urea
4175 2360*
1475 296**
9049 7664
0.4871 0.4198
28.62 12.29
5.32 5.19
0.0023 0.0026
0.0093 0.0106
0.0453 0.0613
5.432 5.215
0.0016 0.0042**
MPO=units/ml ; B-gluc=units/ml ; SAPNA=ug/ml 
#: Values are Lav MPO/cell X 10000 
* No Tx and Urea < Indo and NDGA [p<0.05]
** Urea < all other groups [p<0.05]
*** Urea > all other groups [p<0.05]
Table IX: Time
Time
Variable[/u l ]
WBC[/u l ] 
Segs[/ul]
Lav Cells[/ul] 
Ser MPO @
Ser B-gluc @
Lav SAPNA @
Lav SAPNA/cell 
Lav MPO @
Lav MPO/cell # 
Lav B-gluc @
Lav B-gluc/cell
4 hr 24 hr
3043 4018 *
1030 1026 NS
10565 5830 *
0.4707 0.3124 *
23.21 10.98 *
4.89 6.18 *
0.0009 0.0042 *
0.0072 0.0119 *
0.01 0.0704 *
7.22 4.19 *
0.0011 0.0034 *
MPO=units/ml ; B-gluc=units/ml ; SAPNA=ug/ml 
#: Values are Lav MPO/cell X 10000 
* Significantly different [p<0.05]
NS: Not Significantly Different
Table X: Phi X Treatment
Treatment
Variable[/ul ] None Indo NDGA Urea PBS
WBC[/ul] 2664 2734 2417 985 4490
Segs[/ulj 1057 1266 1062 140 860
Lav Cells[/ul] 4615 5053 7470 8196 10410
Ser MPO @ 0.5648 0.274 0.6415 0.5758 0.262
Ser B-gluc @ 0 0.15 5.7 7.13 18.6
Lav SAPNA @ 4.6 5.37 4.13 4.75 6
Lav SAPNA/cell 0.0088 0.0031 0.0023 0.0036 0.0008
Lav MPO @ 0.0093 0.0074 0.0087 0.0071 0.0083
Lav MPO/cell # 0.0613 0.0399 0.0856 0.0923 0.0088
Lav B-gluc @ 4.29 9.36 2.9 7.41 0.36
Lav B-gluc/cell 0.0017 0.0054 0.0009 0.0084 0.00004
MPO=units/ml ; B-gluc=units/ml ; SAPNA=ug/ml 
#: Values are Lav MPO/cell X 10000
* NDGA Phi & non-pretreated PBS < Urea Phi [p<0.05]
Table X I ; Carbon X Treatment
Treatment
Variable!/u l ] None Indo NDGA Urea
WBC[/ul] 3888 4297 5011 2640 NS
Segst/ul] 1452 1201 1724 417 NS
Lav Cells[/ul] 11091 7784 11344 9052 NS
Ser MPO @ 0.4544 0.2536 0.4292 0.3679 NS
Ser B-gluc @ 18.3 35.8 36.82 18.6 NS
Lav SAPNA @ 5.38 7'. 44 5.9 5 NS
Lav SAPNA/cell 0.0007 0.0014 0.0016 0.0013 NS
Lav MPO @ 0.0108 0.0095 0.0085 0.0157 NS
Lav MPO/cell # 0.0199 0.0222 0.0192, 0.0467 NS
Lav B-gluc @ 10.03 7.58 9.69 6.99 NS
Lav B-gluc/cell 0.0013 0.0022 0.0027 0.0012 NS
MPO=units/ml ; B-gluc=units/ml ; SAPNA=ug/ml
#: Values are Lav MPO/cell X 10000
NS: Not Significantly Different
Table XI I : PBS X Treatment
Treatment
Variable[/ul] None Indo NDGA Urea
WBC[/ul] 4490 4164 5569 3982 NS
Segs[/ul] 860 880 1713 400 NS
Lav Cells[/ul] 10410 5041 6344 5405 NS
Ser MPO @ 0.262 0.3203 0.456 0.2897 NS
Ser B-gluc @ 18.6 18.26 33.84 11.92 NS
Lav SAPNA @ 6 6.64 6.3 6.08 NS
Lav SAPNA/cell 0.0008 0.0021 0.003 0.0018 NS
Lav MPO @ 0.0083 0.0092 0.0121 0.0116 NS
Lav MPO/cell # 0.0088 0.0387 0.0452 0.0238 NS
Lav B-gluc @ 0.36 0.46 0.19 0 NS
Lav B-gluc/cell 0.00004 0.00007 0.00008 0 NS
MPO=units/ml ; B-gluc=units/ml ; SAPNA=ug/ml 
#: Values are Lav MPO/cell X lOOOO 
NS: Not Significantly Different
Table XIII: Inoculation Time \ 4 hr 1
Inoculum
Variable[/ul] Phi O 
1
PBS
WBC[/ul] 2476 4111 2089 *
Seg s[/ul] 942 1321 659 NS
Lav Cells[/ul] 12939 10328 8242 NS
Ser MPO @ 0.619 0.4074 0.375 NS
Ser B-gluc @ 1.16 40.26 22.2 **
Lav SAPNA § 4.26 4.69 5.71 NS
Lav SAPNA/cell 0.001 0.0005 0.0011 NS
Lav MPO § 0.0074 0.0079 0.0006 NS
Lav MPO/cell # 0.0095 0.0094 0.0117 NS
Lav B-gluc @ 7.49 10.97 0.4 ***
Lav B-gluc/cell 0.0014 0.0015 0.0001 NS
MPO=units/ml ; B-gluc=units/ml ; SAPNA=ug/ml 
#: Values are Lav MPO/cell X 10000 
* C > PBS [p<0.05]
** Phi < C [p<0.05]
*** C> Phi > PBS [p<0.05]
NS: Not Significantly Different
Table XI V ; Inoculation X Time [24 hr 1
Inoculation
Variable[/ul] Phi C PBS
WBC[/ul] 1665 3970 6430 *
Segs[/u l ] 678 1226 113 NS
Lav Cells[/ul] 1837 9530 5518 **
Ser MPO @ 0.3406 0.3205 0.2914 NS
Ser B-gluc @ 10.5 1.58 17.62 NS
Lav SAPNA @ 5.07 6.96 6.87 NS
Lav SAPNA/cell 0.0074 0.0018 0.0025 ***
Lav MPO @ 0.0087 0.0137 0.0137 NS
Lav MPO/cell # 0.125 0.0411 0.0421 NS
Lav B-gluc @ 4.81 6.62 0.136 ****
Lav B-gluc/cell 0.0075 0.0024 0.00003
@: MPO=units/ml ; B-gluc=units/ml ; SAPNA=ug/ml 
#: Values are Lav MPO/cell X 10000 
NS: Not Significantly Different 
* Phi < C < PBS [p<0.05]
** Phi < C or PBS [p<0.05]
*** Phi > C or PBS [p<0.05]
**** PBS < Phi or C [p<0.05]
***** Phi > C or PBS [p<0.05]
Table X V : Treatment Time [4 hr]
Treatment
Variable[/ul] None Indo NDGA Urea
WBC[/ul] 3257 3218 4238 1651 NS
Segs[/ul] 1102 1257 1581 290 NS
Lav Cells[/ul] 12664 7453 12464 9378 NS
Ser MPO @ 0.4914 0.272 0.6885 0.4532 *
Ser B-gluc @ 19.76 25.4 51.15 9.3 **
Lav SAPNA @ 5.09 4.89 4.87 4.69 NS
Lav SAPNA/cell 0.0005 0.0008 0.0008 0.0014 NS
Lav MPO @ 0.009 0.0065 0.0068 0.0061 NS
Lav MPO/cell # 0.0081 0.0113 0.0118 0.0101 NS
Lav B-gluc @ 9.2 7.67 5.2 6.2 NS
Lav B-gluc/cell 0.0009 0.0014 0.0006 0.0014 NS
MPO=units/ml ; B-gluc=units/ml ; SAPNA=ug/ml 
#: Values are Lav MPO/cell X 10000 
* Indo < NDGA [p<0.05]
** Urea < NDGA [p<0.05]
Table X V I : Treatment X Time [24 hr]
Treatment
Variable[/ul] None Indo NDGA Urea
WBC[/ul] 4271 4337 4122 3247 NS
Segs[/ul] 1354 999 1386 304 NS
Lav Cells[/ul] 5193 5520 6876 5568 NS
Ser MPO @ 0.2943 0.2809 0.308 0.373 NS
Ser B-gluc @ 2.57 14.32 8; 6 16.93 NS
Lav SAPNA @ 5.62 7.66 5.55 5.82 NS
Lav SAPNA/cell 0.0067 0.0031 0.003 0.0039 NS
Lav MPO @ 0.0109 0.0103 0.0111 0.0158 NS
Lav MPO/cell # 0.053 0.0452 0.0666 0.1211 NS
Lav B-gluc @ 1.59 4.77 5.59 4.07 NS
Lav B-gluc/cell 0.0013 0.0029 0.0022 0.0074 NS
@: MPO=units/ml ; B-gluc=units/ml ; SAPNA=ug/ml 
#: Values are Lav MPO/cell X 10000 
NS: Not Significantly Different
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Graph V
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Graph VI
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Graph IX
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